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Abstract
IMPROVING TREATMENT OF LOCAL LIVER ABLATION THERAPY WITH
DEEP LEARNING AND BIOMECHANICAL MODELING
Brian Mark Anderson, M.S
Advisory Professor: Kristy K. Brock, Ph.D.
In the United States, colorectal cancer is the third most diagnosed
cancer, and 60-70% of patients will develop liver metastasis. While
surgical liver resection of metastasis is the standard of care for treatment
with curative intent, it is only available to about 20% of patients. For
patients who are not surgical candidates, local percutaneous ablation
therapy (PTA) has been shown to have a similar 5-year overall survival
rate. However, PTA can be a challenging procedure, largely due to spatial
uncertainties in the localization of the ablation probe, and in measuring
the delivered ablation margin.

For this work, we hypothesized that biomechanical modeling could
be used to reduce the spatial uncertainties inherent in PTA, f urthermore,
that deep learning could create segmentations that are qualitatively
preferred to manual contours of the liver , delineate the liver structures
vi

rapidly , and predict local progression based on intra -procedural imaging.
Firstly, our study with biomechanical modeling to reduce spatial
uncertainties and measure the minimum distance to agreement found a
significant difference (p<0.01) in the measured delivered minimum
ablation margin between progressing (n=14) and progression -free (n=16)
patients. Secondly, automating the segmentation of the normal liver in
contrast and non-contrast enhanced CT alleviated temporal bottlenecks in
the creation of the biomechanical modeling . In blinded assessment by
three physicians between previously defined manual clini cal contours and
our model contours, the model contours were preferred in 60% (30/50) of
cases, and were created in < 30 seconds. Thirdly, in segmentation of the
disease and ablation zones to reduce segmentation variability , qualitative
evaluation by two radiologists and a radiology -trained physician fellow
found 100%(n=24) of disease segmentations and 84%(16/19) of ablation
zone segmentations had a Likert score of 4 out of a possible 5. Fourthly ,
our outcome prediction model, where we attempt to identify regions of
import to the ablation procedure, reported an area under the curve value

vii

of 0.81. The model also provides visualizations via integrated gradients to
help provide human-interpretable explanations for the model’s decisions.

Our work resulted in the validation of biomechanical modeling in
ablation assessment, creation of automatic segmentation models for the
liver, disease, and ablation volume within our treatment planning system,
and an outcome prediction model. The liv er model has been used to
segment over 1,800 exams in our clinic since 3/23/2021, and our outcome
prediction model provides visual interpretations of model decisions. The
culmination of this work has enabled our on -going Phase 2 Clinical Trial
(NCT04083378). Future studies will improve upon autosegmentation
models, and further investigate outcome-prediction modeling.
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Chapter 1: Introduction
1.1Liver Cancer
1.1.1 Incidence Statistics of Liver Cancer
Liver cancer is the fourth most common cause of death from cancer
worldwide, with the World Health Organization (WHO) estimating over 782,000
new cases each year1 . Liver cancer can either originate from the hepatocytes of the
liver (primary cancer), or as a primary cancer elsewhere that has metastasized
into the liver (secondary cancer). Primary liver cancer is a predominately male
disease, affecting men nearly three times as often as women in similar age groups2 ,
shown in Figure 1.

Figure 1: Age-adjusted incidence per 100,000 of liver cancer among men and women
by region, 2003-2007. 3
1

Liver cancer development is exacerbated by the presence of hepatitis B
virus (HBV), hepatitis C virus (HCV), and obesity-related, non-alcoholic fatty liver
disease (NAFLD)4. With the increasing problem of obesity worldwide, NAFLD has
become a major cause of chronic liver disease. While NAFLD rarely leads directly
to primary liver cancer, it is the first step in the progression to HCC development,
shown in Figure 2.

Figure 2: Development of non-alcoholic fatty liver disease into hepatocellular
carcinoma. Figure take from Obesity, Fatty Liver, and Liver Cancer. Jun Yu et al. 2018
1.1.2 Primary Liver Cancer Therapy
Within primary liver cancer, hepatocellular carcinoma (HCC) is the most
common cancer, accounting for about 80% of all cases, followed by
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cholangiocarinoma (ChC, with about 10-20% of cases), angiosarcoma and
hemangiosarcoma (0.1-2%)5 , and hepatoblastoma (fewer than 1%)1.
HCC and hepatoblastoma are cancers originating from the main type of liver
cell, hepatocytes. However hepatoblastoma typically occurs only in children
younger than 4 years of age6 . ChCs are adenocarcinomas originating in the bile
ducts of the liver, and can be further subdivided based on their origin, as
intrahepatic, hilar, and distal ChC. Angiosarcoma and hemangiosarcoma are
cancers originating from the endothelial cells of the blood or lymphatic vessels.
Surgical liver resection and transplantation offer the best outcomes for
patients suffering from HCC, with studies showing median survival rates after
resection of up to 50 months7 , and 5-year survival rates post-transplantation
exceeding 70%8 . Unfortunately, only about 30% of patients are candidates for
surgery 9–11 , and only a fraction of them (44 - 70%) receive any treatment,
primarily due to a lack of referral to an appropriate specialist 12,13 . While guidelines
for the determination of surgical candidates vary by country, the most widely used
methods are based on the Barcelona Clinic Liver Cancer (BCLC) staging, which has
been endorsed by the American Association for the Study of Liver Disease (AASLD)
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and the European Association for the Study of Liver (EASLD-EORTC) 14,15 , shown in
Figure 3.

Figure 3: Flow-chart of recommended treatments for HCC recommended by AASLD
and EASLD 3 Figure 7.1 p. 87.
Within these guidelines, the Child-Pugh score divides patients into three
groups: A, B, and C, based on serum albumin, bilirubin and prothrombin time,
presence/severity of ascites, and encephalopathy. All of these guidelines correlate
with the severity of the liver disease and/or the likelihood of complications due to
surgery. These guidelines help to establish the standard of care for HCC patients
based on the extent of their disease and other comorbidities. As shown in Figure 3,
4

surgical resection is the treatment of choice for solidary disease, but it has a similar
overall survival rate to liver transplantation and radiofrequency therapy.
1.1.3 Secondary Liver Cancer – Colorectal liver metastasis
Secondary liver cancer is defined as disease that has metastasized from a
primary site that is elsewhere in the body to the liver. The liver is a common place
for secondary metastases to appear due to portal circulation and ‘seeding’ in the
hepatic parenchyma. While metastasis from primary sites of the lung, breast,
melanoma, and pancreas are common, colorectal liver metastases make up about
60% of secondary liver cancer16 .
In the United States, colorectal cancer (CRC) is the third most commonly
diagnosed cancer among both men and women17 , with 25% presenting
synchronous liver metastasis (CRLM), and 60-70% of patients later developing
CRLM over the course of their disease16,18,19 . The primary reason for this high rate
of liver metastasis is due to the relationship between the liver and portal-venous
circulation.
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Figure 4: Relationship between liver and portal-venous circulation. Take from Figure
1 19 .
1.1.3.1 Diagnosis and Imaging
CRLMs can be asymptomatic and are routinely checked for in CRC patients.
There are several techniques for the diagnosis and visualization of CRLM, including
ultrasound, magnetic resonance imaging (MRI), contrast-enhanced computed
tomography (CECT), and positron emission tomography (PET). Examples of MRI,
PET, CT, and PET-CT scans of CRLM are presented in Figure 5.
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Figure 5: Comparison of different diagnostic modalities for colorectal liver
metastasis. The clinical scenario is bilateral liver metastasis from colorectal cancer.
(A) Contrast-enhanced computer tomography (CECT). (B) Contrast-enhanced
magnetic resonance (diffusion-weighted images). Arrows point to metastatic
deposits. (C) Functional study with fluorodeoxiglucose positron emission tomography
(FDG-PET). (D) Fusion of FDG-PET and CT (PET-CT). (3 – Figure 21.1)
1.1.3.1a Ultrasound
There are several benefits to ultrasound and contrast-enhanced ultrasound.
They are relatively inexpensive and portable, and they provide image visualization.
However, two primary drawbacks are the limited range of ultrasound into the liver
and an inability to differentiate between CRLM and other solid tumors20 .
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1.1.3.1b Magnetic Resonance Imaging (MRI)
MRI provides both high sensitivity and high specificity for identifying
CRLM21 . For example, Berger-Kulemann et al. has shown that T1-weighted
imaging can be very successful in the identification of CRLM. In particular, certain
fast spoiled gradient echo T1-weighted images, with a gadolinium-based contrast
agent, have demonstrated sensitivities as high has 92% for lesions smaller than or
equal to 1 cm in diameter, with an acquisition time of 120 seconds22 . The same
work showed a significantly higher area under the curve (AUC) for lesions smaller
than or equal to 1 cm in diameter between MRI and CECT (0.685 vs 0.961), but a
slightly worse AUC for lesions larger than 1 cm (0.976 vs 0.942). While MRI is
considerably more expensive than ultrasound or CECT, it still has significant
advantages in its ability to differentiate tissues.
MRI does have the limitation of a longer acquisition time than ultrasound or
CECT, which can lead to breathing artifacts in the images of liver and particularly
of the dome of the liver.
1.1.3.1c Contrast Enhanced Computed Tomography
CECT remains the gold standard for the identification of CRLM, mainly due
to the speed that is afforded by modern multi-detector row helical CT scanners23 . A
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CECT examination can comprise multiple ‘phases’ depending on the timing after
contrast injection. The three phases of the scan can be generally defined as arterial,
portal-venous, and washout. The amount of contrast that is administered is often a
function of the patient’s weight, although work has shown that the patient’s body
mass index (BMI) should also be considered24 .
The arterial phase occurs approximately 15-40 seconds after aortic arrival
(10-15 for early arterial) 25 , when the majority of the contrast is present within the
arteries and organs that receive blood from the arteries. This time is recorded after
aortic arrival, not injection, as the patient-specific heart capacity can vary the
timing from injection to aortic enhancement. The portal-venous phase is typically
70-80 seconds after aortic enhancement and is so named due to the contrast
enhancement seen in the liver parenchyma via the blood supply from the portal
vein.
The delayed, or ‘washout’ phase is typically 6-10 minutes after aortic
enhancement and will demonstrate the loss of contrast enhancement in most of
the organs by this time, usually remaining only in fibrotic tissue.
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Primary and metastatic disease sites most often appear as hypo-dense in
the arterial phase, and in the portal-venous phase, which is shown in Figure 6.
CECT has the benefit of being a particularly fast acquisition (which is achievable
within a single breath-hold) and can be used within a surgical suite that is
equipped with a CT on rails when required.

Figure 6: Colorectal liver metastasis (red) contoured on portal-venous
phase of contrast enhanced computed tomography scan
With regard to lesion size, for lesions larger than 10 mm in diameter,
research has shown CECT to have an area under the curve (AUC) of 0.97626 .
Several studies have reported a high sensitivity of greater than > 93%26–28 . CECT
fairs more poorly than MRI with regard to lesions less than 10 mm in diameter,
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with an AUC of only 0.685, a mean sensitivity of only 26% (13/50), and a positive
predictive value (PPV) of only 93% (13/14)26 . Furthermore, CECT differentiates
poorly among necrotic, fibrotic, and cystic lesions, which can lead to false positives
if it is used for diagnostic purposes without concomitant PET.
1.1.3.1d Positron Emission Tomography
Positron emission-tomography (PET) utilizes 18-fluoride deoxyglucose
(FDG) as the radiotracer to identify hyper-metabolic tumors within the liver. FDG
contains a positron emitting radionuclide, which will emit two anti-parallel 511
keV annihilation photons upon interaction with an electron. The emitted antiparallel photons are absorbed by scintillation crystals and converted into visible
light. This light is magnified via paired photomultiplier tube and converted into a
current pulse. A popular crystal choice is bismuth germinate (BGO), as its high
atomic number leads to increased interactions with incident photons.
Event positioning within the crystal is improved with inter- and intra-plane
septa, reducing the scattered photon contribution and overall counts. Coincidence
circuitry is particularly important to determine if two measured events should be
considered for a line of response. Patient attenuation correction of the exiting
photons can be performed with combined PET-CT. FDG-PET has been previously
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shown to have a pooled sensitivity of 94.1% (91.6-95.9%), compared to FDGPET/CT with a pooled sensitivity of 96.5% (94.2-97.9%), P=0.02529 . The
limitations of PET imaging include difficulty with detection of sub-centimeter
lesions and long acquisition times. Furthermore, the higher the energy of the
released positron, the farther distance it will travel before annihilation, which
thereby decreases the spatial resolution.
1.1.3.2 Therapy Options
While surgery is the standard of care for the treatment of colorectal liver
metastases with curative intent, with 5-year survival rates of approximately 56%,
only 20% of patients are surgical candidates at the time of diagnosis30 , surgery can
be precluded due to extent of disease, disease location, or comorbidities31–36.
Percutaneous thermal ablation (PTA) is a standard procedure for patients
who are not surgical candidates. PTA has the best results for patients with a single
tumor that is less than 5 cm in diameter, or with two or three lesions each of which
is smaller than 3 cm in diameter, is lacking in vascular invasion, and has a ChildPugh class of A or A-B14,37 .
PTA is often accomplished via microwave (MWA) ablation or
radiofrequency ablation (RFA). Both treatments serve to increase the temperature
12

of disease and proximal tissues above 60 °C, which effectively destroys the
neoplastic tissue by coagulative necrosis38 .
The limitations of ablation therapy include contraindications for general
anesthesia, diffuse metastatic liver disease, poor tumor location (abutting liver
hilum or hepatic ducts), biliary dilation, and extrahepatic disease37,39,40 .
1.1.3.2a Radiofrequency Ablation
RFA raises local temperatures via resistive heating from electrical currents
in the radiofrequency range. A complete circuit is created from a needle electrode
to grounding pads that are typically placed on the patient's thighs or back. Multiple
electrodes can be used within a single procedure to create the desired ablation
zone. Due to the nature of heating and the perfusion of the tissues, RFA is known to
suffer from the heat-sink effect. This can make it difficult to achieve the minimum
required heating proximal to large vessels, and can result in uncertainty in the size
and shape of the ablation zone38.
1.1.3.2b Microwave Ablation
MWA achieves local heating via alternating magnetic fields41 . The
alternating magnetic fields propagate depending on tissues’ relative permittivities,
not local conduction, making them robust to nearby heatsinks. They have been
13

shown to produce large and consistent ablation zones42,43 . An example of MWA
with CECT is shown in Figure 7.

Figure 7: Contrast-enhanced computed tomography post-percutaneous ablation
therapy.
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1.2 Deformable Image Registration
The liver is a very deformable organ. It sits beneath the lungs and has been
shown to move in the craniocaudal direction up to 2.5 cm during normal
respiration44 . These deformations can be exacerbated during the PTA procedure
due to patient rotation, hydro-dissection, and positioning on the surgical table, as
shown in Figure 8.

Figure 8: Pre-treatment contrast enhanced CT on diagnostic CT vs intra-treatment
contrast enhanced CT on surgical table with patient rotation (blue arrow).
Simple rigid registration is not always sufficient to account for the
deformations that are present, as shown in Figure 9. Work by Paulson et al.
demonstrated an average maximum rigid body error (RBE) with implanted
fiducials of 3.36 cm and a maximum RBE of 11.3 cm45.
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Figure 9: Rigid registration between a pre-treatment contrast enhanced CT and posttreatment contrast enhanced CT does not accurately align the dome of the liver.
Image intensity-based deformation has been shown to be very effective for
single organ image registration46–48 . In particular, mutual information (MI) has
become very popular since it was first described by Viola Wells et al.49
Unfortunately, intensity-based MI registration relies on similarities in the
presented intensity, which can vary depending on a number of factors in CECT that
are discussed above in 1.1.3.1c Contrast Enhanced Computed Tomography.
Finite element modeling (FEM) calculates the deformation independently of
intensity values. The basis of FEM is to subdivide a large system into smaller parts,
i.e. ‘finite elements’. Properties of these elements are defined and used to solve
partial differential equations, such as heat transfer, fluid flow, or physical
deformation, subject to their respective boundary conditions.
For deformation purposes, a surface mesh of the segmented organ defines
the boundary conditions between two time points, and assigned the internal
16

material properties (Poisson’s ratio and Young’s Modulus) allow internal
structures to deform accordingly 50 . Our work focuses on an implementation of a
novel finite element model-based multi-organ deformable image registration
method, Morfeus51 , which is demonstrated as deforming between a planning CT
and kV cone beam CT, something that a MI algorithm would struggle to perform, as
shown in Figure 10.
Figure 10: “The Morfeus Algorithm:
Contours of the liver and tumor from the
planning CT are converted into a
volumetric mesh with assigned material
properties. Contours of the liver from the
kV CBCT are converted into a surface
mesh. Boundary conditions are
determined from the surface correlation
of the livers, which generates boundary
conditions. These boundary conditions
are used to solve for the deformation map
of the entire liver volume, including the
tumor, using finite element analysis” 52

This method has been extensively
validated on several anatomical sites including: head and neck, lung, liver,
stomach, esophagus, pancreas, prostate, rectum, cervix, and extremity 50,52–63 .

17

Work by Velec et al. has extensively demonstrated the potential error in
intensity-based deformable registration when low-intensity variation is present
and how Morfeus was a desirable alternative64 .

1.3 Machine Learning in Healthcare
Machine learning has been a part of the healthcare system for years.
Computer-aided detection (CADe) and computer-aided diagnosis (CADx)
algorithms have been the fostering ground of many research projects and
dissertations. The idea of using computers to assist in the treatment of patients is
not a new one, but the methods of using those computers have evolved rapidly
over the past decade, especially with the growing prominence of Deep Learning.
The impact on the field can be seen by the number of publications in Deep
Learning from January 2006 – June 2017

65 , as

shown in Figure 11.
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Figure 11: Growth of the number of publications in Deep Learning, Sciencedirect
database (Jan 2006-Jun 2017*).65 *Note that data stops in June 2017
1.3.1 What is Deep Learning?
At a high level of abstraction, everything that enables computers to mimic
human behavior (prediction, diagnosis, even sending an e-mail) is defined as
Artificial Intelligence (AI). Within AI, there is a subset defined as Machine Learning,
which uses loss-minimization or separation to drive model convergence. Common
Machine Learning techniques can include regression, clustering, ensemble models,
and even neural networks and deep learning. A diagram describing the
relationships among AI, Machine Learning, and Deep Learning, shown in Figure 12.
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Figure 12: Relationship between Artificial Intelligence, Machine Learning, and Deep
Learning.
1.3.1a Example Deep Learning
The largest distinction between Deep Learning and traditional Machine
Learning models is in how the data is required to be presented to the model. To
help illustrate this, I will use an example of a binary classification model to identify
if a stop sign is present in Figure 13.
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Figure 13: Image of a stop sign to be identified Stop sign - Wikipedia
1.3.1b Classic Machine Learning Feature Extraction
Most Machine Learning techniques employ two main steps: 1) identify
features that allow the model to identify or separate groups and 2) train the model
based on examples. A schematic workflow for classic Machine Learning, shown in
Figure 14.
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Figure 14: General pseudo-workflow of ‘classic’ machine learning. Handcrafted
features are extracted with some optimization separating the ‘positive’ and ‘negative’
classes.
Step 1, feature creation, can entail the user drawing upon knowledge from
his or her understanding of the problem, or from a library of features presented by
other groups or researchers.
For example, a user could try to identify if an octagon is present within an
image based on vertical, horizontal, and diagonal lines. In this way, the user is
taking personal knowledge to create features that he or she believes to be intrinsic
to a stop sign.
Feature refinement can be applied to remove features that do not provide
useful information using univariate analysis. Further pruning can remove features
that are highly correlated and thus do not provide new information. Popular
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estimations for this purpose include Pearson and Spearman’s correlation scores. In
this way, the user tries to identify a set of features that are not only able to best
identify the group, but also does so efficiently as each provides unique information.
Step 2, training the classifier involves separating the features into distinct
groups, attempting to achieve a separation in prediction between the positive and
negative groups, and gain a desired sensitivity and specificity.
The largest challenge with classical machine learning is the reliance upon
proper feature selection. Common approaches are to include a wide variety of
potential features, and then to reduce the features to only those that are most
important.
This leads to one of the largest differences between ‘classic’ Machine
Learning and Deep Learning: feature extraction.
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1.3.2 Deep Learning Components
Deep learning architectures involving images are typically composed of four
main components: local convolution kernels, pooling layers (globally and locally),
fully connected (dense) layers, and activations (linear and non-linear). The
combination of these four parts is useful in a variety of disparate tasks, from
classification66–71 and image segmentation72–79, to image discrimination and
generation80–82 .
1.3.2a Convolutional layers
Convolutional layers are defined based on two parts: a kernel and a bias.
The kernel is a matrix that will be convolved locally across the image. It typically is
symmetrical. The convolution layer functions by multiplying the values within the
kernel with the voxels in the image or feature map, depending upon the layer of
the model, summing the result and adding the bias, shown in Figure 15. The
resultant output will be referred to as a feature map.
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Figure 15: Example of convolution filter (Sobel Gx) applied to an image. (Source :
https://datascience.stackexchange.com/questions/23183/why-convolutions-alwaysuse-odd-numbers-as-filter-size/23186)
Convolution kernels suffer from local dependency. Since the kernel size is
fixed, images of different magnification and scale might not properly align with the
defined kernel. While an immediate solution might be to increase the size of the
kernel, each increase will significantly increase the number of parameters as the
number of parameters in an n x k matrix is n * k + 1, (e.g., a 3x3 matrix has 10
parameters, and an 11x11 has 122 parameters). To remedy this challenge, pooling
layers are often employed.
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1.3.2b Pooling Layers
Local Pooling
Pooling layers come in a variety of forms, although the most common is
called max pooling. Pooling layers are similar to convolutional kernels in a local
region defined by their kernel size (typically of size 2x2 for 2D images), but rather
than multiplying and adding, a max pooling feature will take only take the
maximum-valued feature within the kernel, shown in Figure 16.

Figure 16: Example of a 2x2 max-pooling layer on a 2D image. Only the maximum
value within each 2x2 square is transferred onto the next step.
The first benefit of max pooling is that the maximum feature from the
previous layer is maintained, while the information that is removed is presumably
less important. Second, in an n by k pooling, the entire search space is reduced by a
factor of n and k. This means that the program now has a factor of n*k fewer
computations to run, and, relative to the previous feature map, the kernels will
cover n*k times more area in the original image.
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Pooling layers do have disadvantages, as they lead to the degradation of
spatial information. To illustrate this, a screen shot of the previous page is run
through up to five max pooling layers and then resampling back to the original
image with bilinear resampling, shown in Figure 17.

Figure 17: Illustration of multiple MaxPooling layers and bilinear resampling to
illustrate how fine resolution information (text) is quickly lost, while large
information (general colors) remains.
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The max pooling has ‘smeared’ out many of the words after only two
pooling layers, blurring them together in a way that is not accurately reconstructed
when interpolating back to the original size.
Global Pooling
In some cases, the pixel of the features might itself be multi-dimensional.
The global max pooling layer takes the maximum-valued feature value in the
feature axis, typically the last axis. For example, in the color image with red, green,
and blue channels that is shown in Figure 17, a local max-pooling layer would
convert the 200x200x3 image into a 100x100x3 array, where each channel in the
RGB image has the maximum intensity value of the local 2x2 region. In global max
pooling, only the largest feature value across the feature’s channels is kept,
resulting in a 200x200x1 image, shown in Figure 18.

Figure 18: Example of a 2x2 global max-pooling layer on a 2x2 RGB image. Only the
maximum value in each 2x2 square across the three channels is retained.
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Global max/average pooling is often employed in classification
networks71,83,84 , as it substantially reduces the number of inputs into the
subsequent fully-connected layers.
1.3.2c Fully-Connected (Dense) Layers
Unlike convolutional layers or pooling layers, fully-connected, or dense,
layers are not locally-dependent. While a 3x3 convolutional kernel can ‘see’ only a
3x3 square of the image, the fully-connected layers receive input from every aspect
of the vector. Before fully connected layers can be implemented, tensors must be
converted into a vector. For example, a 128x128x1 tensor would turn into a 16,384
vector. Dense layers function as a mapping from a series of input values into a
desired number of output values, shown in Figure 19. The output values of the ith
layer can be described as ℎ 𝑜𝑢𝑡
= 𝐹𝑖 (ℎ 𝑜𝑢𝑡
𝑖
𝑖−1 ∗ 𝑊𝑖 + 𝐵𝑖 ), where Fi is an activation
function, Wi is the weighting matrix and Bi is the bias.
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Figure 19: Fully connected, or Dense, layer. Output values (red) are defined as a
function of a combination of weights from each input value (blue).
Dense layers are often employed after feature extraction from convolution
and pooling layers in image classification tasks. Dense layers are ‘global’ meaning
that they take in every feature and are typically using as the classification layers;
however, this relies heavily on the activation function.
1.3.2d Activations
Activations are a form of mapping of an input to an output and are typically
applied after convolution or dense layers. One of the most basic forms of activation
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is a linear activation: y = mx+b, which can have a scaling (m) and a bias (b) impact
on the outputs.
While linear activations can be a useful way of scaling and shifting values,
additional linearly activated layers do not add any new information to the system.
To demonstrate this, imagine two linear feed-forward layers, where x is the
original vector of values.
𝑦1 = 𝑚1 𝑥 + 𝑏1
𝑦2 = 𝑚 2 𝑦1 + 𝑏2
The entirety of this network y 2 can be defined and simplified as a single
linear activation
𝑦2 = 𝑚 2 (𝑚1 𝑥 + 𝑏1 ) + 𝑏2 → 𝑚 2 𝑚1 𝑥 + 𝑚 2 𝑏1 + 𝑏2 → 𝑀𝑥 + 𝐵
where m2 *b1 + b2 can be combined as a single bias, B, and m2 *m1 can be a
single scalar, M. This means that linearly activated layers are incapable of fitting
data from non-linearly originating data (for example, the parabolic trajectory of a
thrown object).
The strength of deep learning is best found through combinations of nonlinear activations. Multiple non-linearly activating layers are capable of adding
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increasing complexity to a model. For example, if the activation function were y =
mx2 + gx + c, two such layers would have the polynomial presentation of x4, x3 , x2 , x
and bias, easily capable of modeling gravity.
Common activation functions include the sigmoid function, rectified linear
unit (ReLU), leaky-ReLU, and exponential linear unit (ELU), shown in Figure 20.

Figure 20: Plots of common activation functions: sigmoid, rectified linear unit
(ReLU), leaky ReLU, and exponential linear unit (ELU).
Another common activation function is the softmax activation; this provides
a probability of a class scaled to the sum of all class’ probabilities.
𝑃(𝑦 = 𝑐|𝑥) =

𝑒 𝑧𝑐
∑𝐶𝑗=1 𝑒 𝑧𝑗

where c is a particular class and C is the total number of classes.
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1.3.3 Loss Functions
A loss function is the means of measuring the performance of a model
during training. These loss functions guide the optimization process of the model
by providing a desired output compared to the delivered output.
Model optimization is often posed as the minimization of a loss, where the
loss is the difference between a ground truth and a generated prediction. A well
tested loss function for classification and semantic segmentation with multiple
classes is the categorical cross entropy.
𝐶𝑎𝑡𝑒𝑔𝑜𝑟𝑖𝑐𝑎𝑙 𝐶𝑟𝑜𝑠𝑠 𝐸𝑛𝑡𝑟𝑜𝑝𝑦 (𝑝, 𝑞) = − ∑ 𝑝 (𝑥) ∗ log (𝑞 (𝑥))
For example, in the classification of a stop sign, if the ground truth were
defined as a two class problem: the probability of background or stop sign. We
define this as a vector with two values ranging from zero to one, so the image of a
stop sign is ([0, 1]). If the model predicted that a stop sign is present with 90%
confidence, that prediction would look like ([0.1, 0.9]), and the loss would be
𝐶𝐶𝐸 = −0 ∗ log (. 1) − 1 ∗ log (.9)
Note that because the ground-truth class is ‘0’ we can ignore the first half of
the equation
𝐶𝐶𝐸 = −1 ∗ log (0.9) = 0.05
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Compare this value to a loss if the prediction is [0.4, 0.6]; the loss becomes
0.22, which is much larger than that from the previous guess. In this way, we can
say that the prediction model with the smaller loss would be more accurate and
inspire greater confidence in its predictions.
Simply having an incorrect prediction does not help the model identify a
better solution. The next step is to take these learning instances and update the
previous weights to gain more confidence in the correct predictions with
backpropagation.
1.3.4 Backpropagation
Neural networks update their weights based on the propagation of the error
between the output predictions and the ground truth, which is referred to as ‘loss’.
These weight updates are passed along from the last layer of the network to the
beginning of the network by leveraging an understanding of differentiation and the
chain rule of derivatives.
A neural network can be expressed as a series of mathematical
multiplications between input variables and weights, followed by a summation of
bias, and finally an activation. Weight updates are passed along from the final layer
back towards the initial layers based on the chain rule of derivatives. The gradient
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between the second to last layer (n-2) and the last layer (n) is the product of the
gradient between the (n) layer and the (n-1) layer and the gradient between the
(n-1) layer and (n-2) layer. The model learning rate and the optimizer both work
to define to what extent the loss will change previous weights.
Unfortunately, this mathematical relationship directly led to the
‘diminishing gradient’ problem when working with deep neural networks built on
sigmoid activations. Since the derivative of sigmoid activation function has a
maximum value of 0.25, the gradient would be diminished by a factor of 0.25, at
best, between each layer.

Figure 21: Plot of sigmoid function (blue) and derivative of sigmoid function
(sigmoid’, red dashed). As seen here, the maximum value from sigmoid’ is 0.25, this
can lead to diminishing gradient of loss with increasingly deep networks.
In a three-layer deep network, the gradient propagated from the end of the
network to the beginning will diminish to 0.25*0.25=0.0625 of the original value,
at best.
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This diminishing gradient problem led to the shift to the ReLU activation
function. The linear region when x > 0 ensures there is no loss in gradient.
However, ReLU activation is not without its own problems. If the network
initializes or ‘falls’ into a region where x < 0, the node can be said to ‘die’, as
anything outside of the linear region goes to zero. For this reason, functions such
as the leaky-ReLU and ELU have become more popular. Even when the network
falls into a region where x < 0, there is still a small gradient, which allows the
model to continue learning.
The shift away from the sigmoid activation did not completely alleviate the
diminishing gradient problem. Increasingly deep networks still had difficulty with
propagating loss. To mitigate this issue from an architectural side, ‘residually
connected’ and ‘densely connected’ architectures were created, as explained
below.
1.3.5 Architectures
Other methods of reducing the diminishing gradient problem and
facilitating learning include residual connections between convolution blocks.
These residual connections were first popularized in a work that termed this
residual network the ResNet83 for the ImageNet challenge. ResNet benefits by
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passing a previous activation as a summation before a later activation, shown in
Figure 22.

Figure 22: (Left) ‘Standard’ convolutional block: input features are convolved and
activated via non-linearity before progression to the next block. (Right) Residual
convolution block: previously activated features are passed and summed to the
output of later blocks before activation.
Unfortunately, the loss propagated backwards through the network is
unable to determine where a specific output comes from after the addition. This
has led to another method, the DenseNet71 .
The DenseNet goes a step further by directly concatenating previous
convolutional outputs, allowing the reuse of layers, shown in Figure 23. Likewise,
in the backwards propagation of loss there is a clear direction as to where each
previous convolution came from.
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Figure 23: (Left) ‘Standard’ convolutional block: input features are convolved and
activated via non-linearity before progression to the next block. (Right) Dense
convolution block: previous convolution outputs are directly concatenated to later
convolutions before activation.
Unfortunately, DenseNets can become computationally expensive with
increasing depth. For this reason, ‘bottleneck’ layers are often implemented, where
a 1x1 or 1x1x1 convolution is used to reduce the concatenated layer depth to a
more manageable size.
1.3.6 Networks presented here
The work presented here relies on two general forms of deep learning
architectures: neural networks for classification, and fully convolutional neural
networks for image segmentation. Classification means that the architecture
determines if a certain object is present in the image, regardless of the object's
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location, size, or orientation. Segmentation aims to identify every pixel in the
image that relates to a specific object, shown in Figure 24.

Figure 24: (Left) A classification neural network would identify that there is a cat in
the image. (Right) A segmentation neural network would identify which pixels of the
image correspond to the class ‘Cat’.
Image Classification Neural Networks
Classification neural networks are typically built upon two main steps. Step
1 is feature extraction, which is typically accomplished through a series of
convolutional and pooling layers. Step 2 typically is fully connected layers, which
provide dense connections to understand how these features combine to
determine what is present in the image. The visual geometry group-16 (VGG1685 )
architecture shows a series of 13 convolutional layers and 3 dense layers, shown in
Figure 25.
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Figure 25: The visual geometry group 16 (VGG16) architecture. (Top) The VGG16
architecture following input image dimensions and feature size. (Bottom) General
overview of the architecture. Image from https://neurohive.io/en/popularnetworks/vgg16/
Everything to the left of the dense (fully-connected) layers can be
considered to be the feature extraction layers. Early convolutional layers typically
extract high-level and abstract features, such as lines, curves, edges, etc. Deeper
layers tend to specialize into more distinct features, such as the presence of ears or
cat, shown in Figure 26.
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Figure 26: Demonstration of transition of features typically created in neural
networks. Features closer to the input image tend to be more general (e.g. lines,
curves, and edges) while those that are deeper tend to be more class-specific.
Because features are eventually converted into dense connections,
classification architectures typically require an exact statement of the input image
size. For example, the VGG16 architecture requires its input images to be precisely
224x224x3 pixels.
Pre-trained Architectures
Models such as the VGG16 contain what can be referred to as pre-trained
weights. These weights were trained for specific tasks, which can be very distinct
from our own purposes in medical image segmentation. The VGG16 architecture
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was originally created for the ImageNet86 challenge. This challenge provides
millions of images and classifications such as dogs, cats, airplanes, etc. Despite this
architecture having been trained for the task of identifying these objects, it can be
repurposed for other tasks that are completely separate from the original task.
The general idea is that the first several pre-trained convolutional layers are
abstract, e.g. lines, curves and edges, which can be found in a wide variety of
objects, including medical images. In practice, the act of taking a pre-trained
network and repurposing the output is referred to as transfer learning. This is
accomplished by ‘freezing’ the convolution layers (preventing changes to their
weights and biases) and re-training or adding new dense layers.
Another method, which is typically performed after transfer-learning, is
called ‘fine-tuning’. This is accomplished by ‘freezing’ the early feature extraction
layers in the network or preventing the changing of their weights and biases. The
assumption is that incorrect predictions are most often caused by the dense layers
and more specialized convolution filters, rather than by the early abstract layers.
After initial re-training, the early layers are then ‘unfrozen’ for a final optimization.
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Fully convolutional neural networks (FCNN)
Fully convolutional neural networks are neural networks that consist
entirely of convolutional and pooling layers and are typically used for
segmentation tasks. An advantage of fully convolutional networks that are built
solely from convolution and pooling layers is that a pre-determined input image
size is not required. A widely popular fully convolutional neural network is the
‘UNet’, named after the way the encoding and decoding sides create the semblance
of ‘U’, shown in Figure 27.

Figure 27: General ‘UNet’. Left side shows the encoding aspect as the input image
goes through convolution and max pooling layers. Right side shows the decoding
aspect with up-sampling and concatenation layers.
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The UNet-style architecture has two main advantages that help in the
segmentation task, and it has been successfully adapted to the segmentation of
multiple sites in medical imaging73,74,79,87–91 :
1) Progressive encoding layers allow for large scale information to be
identified in the image
2) Low-level, fine-resolution features from the encoding convolution layers
are preserved through the concatenation layers across the network
This progression of previous feature maps and the inclusion of ‘deeper’
layers help the model to identify both where an object is located within the image,
and the boundaries of said object.
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1.3.7 Difficulty with Deep Learning
One of the largest criticisms of Deep Learning is the issue of the prediction
model becoming a ‘black box’. Essentially, the deeper or more complex the model
algorithm, the more difficult it becomes to explain exactly why the decision was
reached, as multiple inputs are now feeding into the final prediction, shown in
Figure 28.

Figure 28: Representation of spread in different machine learning techniques for
prediction vs their ability to give meaningful explanations to human users.92
This highlights a very important issue within Deep Learning: the difficulty
of users’ interpreting why decisions occurred. Certain methods have been created
to improve the interpretability of Deep Learning predictions: by illustrating what
parts of the image were important in the final decision93 or by creating humaninterpretable sentences explaining the prediction

94 .
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An example of how these methods showed discrepancies between the
imaging and actual pathology is seen with a CNN for determining the presence of
pneumonia in radiographic scans

95 . Using

a gradient camera to determine which

part of the image was most important in the prediction of pneumonia, they showed
that for some images, indicators of a portable radiograph such as a laterality
marker were highly important to the prediction of pneumonia, shown in Figure 29.

Figure 29: Gradient camera heat map showing that the presence of the left-side
marker was highly important in the prediction of pneumonia.
We already know that a portable radiograph is correlated with poorer
patient health, as it means the patient is unable to go to the standard radiography
machine (due to either poor health or other factors), but humans also know that
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the radiograph’s being portable has nothing to do with the patient’s pathology.
This is why it is vitally important to be aware of the training of a deep learning
model and perform extensive testing on its limitations.
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Chapter 2: Specific Aims and Central Hypothesis
2.1 Central Hypothesis:
While the overall hypothesis for this work is that probe guidance and
ablation assessment, facilitated by biomechanical modeling, will result in increased
progression-free survival rates, this will take several years to prove. Therefore, my
central hypothesis is that probe guidance and ablation assessment, using
biomechanical modeling and augmented with artificial intelligence for efficiency,
will make a significant improvement in the measured minimum ablation margin.

2.2 Specific Aims
2.2.1 Specific Aim 1: The evaluation of local progression using biomechanical
deformation to reduce spatial uncertainties
Goal: Differentiate between locally progressing and non-locally progressing
patients who have undergone percutaneous ablation therapy.
Hypothesis: Biomechanical models can reduce spatial uncertainty, to the
extent that the measured minimum ablation margin will differentiate between
locally progressing and non-locally progressing patients and will spatially
correlate with recurrence.
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Study 1: Identify the optimal parameters for biomechanical registration
based on target registration error (TRE).
Study 2: Determine if the measured minimum ablation margin can
differentiate patient groups with local progression from those without local
progression.
Study 3: Determine if the measured minimum ablation margin in locally
progressing patients corresponds spatially to actual progression.
2.2.2 Specific Aim 2: Creation of a deep learning neural network to delineate
the liver structure, metastatic tumor, and ablation zone.
Goal: Create a deep learning convolutional neural network for segmentation
of the liver structure, colorectal liver metastasis, and ablation zone.
Hypothesis: Fully convolutional neural networks can be tasked for humanlike segmentation of normal and diseased structures in the liver.
Study 1: Develop a segmentation model for contrast and non-contrast
enhanced liver scans that are similar to what are likely to be seen in interventional
radiology.
Study 2: Develop a 3D segmentation model to identify the segments of the
liver on contrast-enhanced CT scans.
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Study 3: Develop a segmentation model for both colorectal liver metastasis
in contrast-enhanced CT pre-treatment imaging and ablation zones in contrastenhanced CT post-treatment imaging.
2.2.3 Specific Aim 3: Creation of a deep learning outcome predictions model
to predict the likelihood of local progression following ablation therapy
based on intra-treatment imaging.
Goal: Create a deep learning prediction network to predict the likelihood of
local progression
Hypothesis: Image features that are extracted with convolutional networks
from the contrast-enhanced pre-treatment CT and contrast-enhanced posttreatment CT can be used with densely connected layers to predict the likelihood
of local progression.
Study 1: Develop an outcome predictions model on a site-by-site basis
based on collected progression data of disease sites.

2.3 Organization of Thesis
The specific aims for this work are broken up into three chapters, with
Specific Aim 1 addressed in Chapter 4: The evaluation of local progression using
biomechanical deformation to reduce spatial uncertainties. Specific Aim 2 is
addressed in Chapter 5: Deep learning autosegmentation of liver structure: liver,
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disease, ablation zone, and liver lobes. Specific Aim 3 is addressed in Chapter 6:
Deep learning outcome predictions model. Work performed to facilitate our deep
learning models is addressed in Chapter 3: Technology created to facilitate work.
A discussion of the work including limitations, potential future work, and
the impact of this work on the field is presented in Chapter 7: Discussion and
Future Work.
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Chapter 3: Technology created to facilitate work
Technical Report: Practical Radiation Oncology
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3.0 Abstract
Deep learning is becoming increasingly popular and available to new users,
particularly in the medical field. Deep learning image segmentation, outcome
analysis, and generators rely on the presentation of Digital Imaging and
Communications in Medicine (DICOM) images, and often on the use of radiation
therapy (RT) structures as masks. While the technology to convert DICOM images
and RT-Structures into other data types exists, no purpose-built Python module for
converting NumPyarrays into RT-Structures exists. The two most popular deep
learning libraries, TensorFlow and PyTorch, are both implemented within Python,
and we believe a set of tools built in Python for manipulating DICOM images and
RT-Structures would be useful and could save medical researchers large amounts
of time and effort during the pre-processing and prediction steps. Our module
provides intuitive methods for rapid data curation of RT-Structure files by
identifying unique region of interest (ROI) names, ROI structure locations, and
allowing multiple ROI names to represent the same structure. It is also capable of
converting DICOM images and RT-Structures into NumPy arrays and SimpleITK
Images, which are the most commonly used formats for image analysis and inputs
into deep learning architectures, and for radiomic feature calculations.
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Furthermore, the tool provides a simple method for creating a DICOM RTStructure from predicted NumPy arrays, which are commonly the output of
semantic segmentation deep learning models. Accessing the DicomRTTool via the
public Github project invites open collaboration, while the deployment of our
module in PyPi ensures simple distribution and installation. We believe our tool
will be increasingly useful as deep learning in medicine progresses.

3.1 Introduction
Deep learning has become increasingly popular in the medical community,
particularly for semantic segmentation74,96–107 . As medical professionals begin to
explore the creation of deep learning architectures, the number of people who
need to process medical images to create both input for deep learning networks
and radiation therapy (RT) structures from predictions will continue to grow. The
Python programming language108 has become the most widely used programming
language worldwide (http://pypl.github.io/PYPL.html), and is the base for the two
most popular deep learning libraries: TensorFlow109 and PyTorch110 . While
technology (e.g., PlastiMatch111 ) to convert Digital Imaging and Communications in
Medicine (DICOM) images and RT-Structures into other common data types (.nii,
.nrrd, etc.) exists, there is currently no single purpose-built python module for
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converting prediction arrays back into DICOM RT-Structures. We believe the
distribution of simple DICOM tools, created in Python, could save medical
researchers large amounts of time during the pre-processing and prediction steps
of deep learning. Here we describe our program, DicomRTTool, which is designed
to streamline several of the most time-consuming aspects of data preparation by
quickly identifying unique region of interest (ROI) names, where image sets with
all ROIs are located, and converting DICOM images and RT-Structures into NumPy
arrays112 and SimpleITK images113 . It also allows for the conversion of prediction
NumPy arrays to DICOM RT-Structures.
The coding community has a wonderful basis of sharing ideas and code
structure. While I created this tool for my own purposes, I felt that it was
particularly important to write it in such a way that it could be beneficial to others.

3.2 Materials and Methods
To demonstrate our program’s capabilities we have created a Juypter
notebook, Supplemental Material, which walks through the capabilities of our
program: 1) Getting Data, 2) Reading Dicom and RT-Structure, 3) Saving as nifty, 4)
Saving/loading NumPy, 5) Calculating radiomics, and 6) Predictions to RTStructures, on a publicly available brain tumor dataset114 .
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3.2.1 Installation
The DicomRTTool software is available through both Github
(https://github.com/brianmanderson/Dicom_RT_and_Images_to_Mask) and PyPi
(https://pypi.org/project/DicomRTTool/). The list of module requirements is
present in the requirements.txt file, and these are automatically installed when
using pip.
𝑝𝑖𝑝 𝑖𝑛𝑠𝑡𝑎𝑙𝑙 𝐷𝑖𝑐𝑜𝑚𝑅𝑇𝑇𝑜𝑜𝑙
This module is compatible with Python3.x versions and above, on Windows
and Linux machines.
3.2.2 Data Preparation
Leveraging SimpleITK’s ability to rapidly identify series instance unique
identifies (UIDs), our model is able to separate and group DICOM images and RTStructure files based on UIDs and referenced series instance UIDs, respectively,
even when they are not present within the same folder. The module leverages
threading and multi-processing, thereby reducing time bottlenecks even when
walking through multiple nested structures and patients.
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3.2.3 Loading DICOM Images and RT-Structures
The DicomReaderWriter is built as a Python Object class, allowing the
module to be initialized once and used multiple times. To specify the behavior of
the DicomReaderWriter, several arguments can be passed. We maintain an
updated description of arguments on the GitHub Wiki page
(https://github.com/brianmanderson/Dicom_RT_and_Images_to_Mask/wiki) and
recommend that readers inspect the latest version.
When RT-Structures are found, the list of the ROIs that are present within
the structure is automatically added to the module by reading the
StructureSetROISequence Dicom tag. This allows for the user to investigate ROI
structures without tediously reloading them. All ROI names are automatically put
into lowercase. Following TG-263 guidelines, capitalization should not be used to
distinguish ROIs. Please note that this is only for loading masks and will not affect
the ROI names present in the RT-Structures in any way.
Upon completion, the module will have a list of indexes, each associated
with a unique UID for the image and RT-Structures. By default the module starts
with index=0, but the user can set the desired index at any time using
.set_index(index).
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3.2.4 Conversion of DICOM to SimpleITK images and NumPy
The user can load images for a desired index easily using .get_images ().
Images are generated via SimpleITK’s ImageSeriesReader().
The SimpleITKImageHandle can easily be saved as a .nii or .nii.gz file using
SimpleITK’s built-in WriteImage(image=image, fileName=filename.nii). The
SimpleITKImageHandle is beneficial in that it maintains spacing information,
direction, orientation, and origin. If NumPy arrays are desired, the user can
transform an Image to a NumPy array through
simpleITK.GetArrayFromImage(image_handle).
3.2.5 Identification of ROIs present within folders
The DicomReaderWriter can easily identify all of the unique ROI names that
are present within a set of data. This function can be beneficial for quickly
identifying variant ROI names and building an associations file.
Locating RT-Structures by ROIs
If the user would like to locate where an individual ROI name is located, the
DicomReaderWriter compiles a list of RT-Structures that contain a specific ROI
name, using DicomReaderWriter.where_is_ROI(RoiName).
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3.2.6 Conversion of DICOM RT-Structures to NumPy mask and SimpleITK
images from RT-Structure
To create a binary mask of the structure, potentially for deep learning
training, the user will need to specify a list of desired contour names. The module
allows for variations of names with an associations dictionary. This allows the user
to specify that multiple names (e.g. ‘liver_bma’, ‘liver_final’) can all correspond to
the same mask.
Conversion of prediction to DICOM-RT
NumPy prediction arrays from deep learning algorithms can easily be
converted back into DICOM RT-Structures. The module generates a new RTStructure file based on a template file if an RT-Structure is not already present.
Contours are generated from the binary mask using a marching-squares method
within Scikit-image115 .
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Figure 30: Segmentation predictions of a target (red), square (pink), and circle
(green), presented in different treatment planning systems and RT-Structure viewers.
Test contours of a circle, a rectangle, and a ‘target’ were reviewed in four
systems: RayStation116 , vv-Slicer117 , Velocity 118, and 3DSlicer119 , shown in
Figure 30. Raystation, vv-Slicer, and Velocity were able to display all
generated test case contours as expected.
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3.3 Discussion and Conclusion
Python is becoming increasingly popular and widely adopted by new users,
and serves as the base for two of the most-used deep learning libraries111,120 . Our
module offers a simple way of curating and converting patient DICOM and RTStructure data into NumPy arrays and SimpleITK images, with a range of
parameters to benefit each use case. This is particularly important within
Radiation Oncology, which relies on DICOM RT-structures to delineate medically
important areas of treatment planning images. Likewise, conversion of predictions
back to DICOM RT-Structures is necessary for any deep learning segmentation
task. Moreover, while we have constructed our module with deep learning
explicitly in mind as a use-case, our module may also be adapted for other
quantitative imaging applications, such as radiomic feature extraction121,122 .
Being available on GitHub invites open collaboration, and deployment via
PyPi ensures easy distribution. We believe this work will provide a useful tool for
all medical researchers, be they novices or experts, who are involved with deep
learning.
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4.0 Abstract
Purpose
Colorectal cancer is the third most common form of cancer in the United
States, and as many as 60% of these patients develop liver metastasis. While
hepatic resection is the curative treatment of choice, only 20% of patients are
surgical candidates at the time of diagnosis. While percutaneous thermal ablation
(PTA) has demonstrated 24-51% overall 5-year survival rates, the assurance of a
sufficient ablation margin delivery (5mm) can be challenging as current methods
of 2D distance measurement do not ensure the minimum required margin in all
three dimensions. We hypothesized that biomechanical model-based deformable
image registration (DIR) could remove spatial uncertainties and distinguish local
tumor progression (LTP) patients from LTP-free patients.
Materials and Methods
We retrospectively analyzed 30 patients (16 LTP, 14 LTP-free) at our
institution who had undergone PTA and had both contrast-enhanced pretreatment and post-ablation CT scans. Liver, disease, and ablation zone were
manually segmented. Biomechanical model-based DIR between the pre-treatment
and post-ablation CT mapped the gross tumor volume onto the ablation zone, and
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measured the 3D minimum delivered margin (MDM). An in-house developed ray
tracing algorithm determined if progression correlated with an insufficient margin
in the actual treatment.
Results
The Mann-Whitney U test showed a significant difference (p<0.01) in MDM
between the LTP and LTP-free groups. 93% (13/14) of patients with LTP had a
correlation between the site of progression and an insufficient margin.
Conclusion
Biomechanical DIR is able to remove spatial uncertainty and allow the
measurement of the delivered 3D MDM. This minimum margin can help to ensure
curative ablation delivery, and our workflow can provide valuable information in a
clinically useful timeframe.

4.1 Introduction
Colorectal cancer (CRC) is a leading cause of cancer-related death
worldwide123 , and is the third most common cancer in the United States17 . 25% of
CRC patients present with colorectal liver metastasis (CLM) at the time of
diagnosis, and as many as 60% of CRC patients will develop CLM over their
disease course124 . About two-thirds of deaths resulting from CRC are believed to
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be caused by CLM33 . While curative hepatic resection is the treatment of choice for
patients presenting with CLM125, only 20% of patients are candidates for surgery.
For the remaining patients, systemic treatment or other forms of loco-regional
therapy such thermal liver ablation are offered126–129 . Liver ablation has
demonstrated five-year overall survival rates of 24% to 51%130–132 , and achieves
significantly longer overall survival when it is combined with systemic
chemotherapy compared to chemotherapy alone133 .
Minimal radiographic ablation margins have been described as one of the
most relevant factors that are associated with improved local tumor control
following thermal liver ablation134–137138 , with minimum margins of 5 -10 mm
suggested in order to achieve optimal local control 139,140 . Despite its criticality to
successful treatment, ensuring a sufficient ablation margin can be challenging for
several reasons. First, tumor visualization is difficult using the intraprocedural
non–contrast-enhanced computed tomography (CT) or ultrasound images for
tumor targeting and probe guidance because of similar image intensities. Second, it
is nearly impossible to distinguish between diseased and ablated tissue in the posttreatment contrast-enhanced CT scan for hypo-enhancing disease, which prevents
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accurate measurement of the delivered margin. Finally, accurate threedimensional (3D) assessment of the ablation margin is difficult, as rigid
registration can be poor due both to deformation of the liver throughout the
procedure and to the inherent inability to effectively assess the ablation zone
within a constrained intra-procedural time-period without the aid of high-level
computational analysis.
The current methods of ablation assessment often rely on 2D distance
measurement to a visible landmark on the post-treatment imaging, do not ensure
the 3D minimum margin, or rely strictly on rigid registration141,142 . Rigid
registrations can perform poorly in the presence of large deformation, and one
recently published workflow has been shown to terminate when target
registration errors that are greater than 3 mm are present142 , which commonly
occur given both the liver deformations that rise from patient’s breathing and
changes in position143 , and post-ablation volumetric changes. While promising
work leveraging a non-rigid intensity based registration has been previously
shown144,145 , ”good” or “perfect” registration was achieved in only 62% of the cases
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due to differences in liver position, differences in the phase of the respitarory
cycle, or artifacts in the image.
We hypothesized that the minimum ablation margin, calculated following
the use of a biomechanical model-based deformable image registration (DIR),
would differentiate patients with local tumor progression from those receiving a
sufficient ablation delivery. The biomechanical model-based registration that is
used here has demonstrated its accuracy in the presence of differences in liver
position and respiratory phase and is unaffected by image artifacts as long as the
liver boundary can be obtained53,146–148 . We also describe a method for establishing
the relationship between the minimum ablation margin and the region of
recurrence of disease.

4.2 Materials and Methods
The data from 30 patients whose liver metastasis from colorectal cancer
had been treated with local PTA at The University of Texas MD Anderson Cancer
Center were retrospectively evaluated under a prospectively-maintained liver
ablation registry approved by the institutional review board (PA18-0832). Patients
were included if they had had a contrast-enhanced pretreatment CT image within
45 days of the PTA procedure, a post-treatment contrast-enhanced porto-venous
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phase CT scan performed immediately at the end of PTA procedure, and follow-up
imaging depicting either freedom from local progression (mean 660 days) or
evidence of local progression. The cohort comprised 14 patients with post-ablation
local tumor progression (LTP) and 16 without LTP. The relevant characteristics of
these patients are listed in Table 1.
Table 1: Patient Characteristics.
Characteristic

Local Recurrence (N = 14)

Local Control (N = 16)

Male

8

11

Female

6

5

Age, y, mean (range)

60 (33-78)

57 (36-78)

209 (178, 64-554)

888 (660, 76-2501)

Gender

Followup/recurrence*, d,
mean (median, range)
* Follow-up is the time from the procedure to recurrence or the last diseasefree scan.
4.2.1 Imaging Data
Tri-phasic (arterial, portal-venous, delayed) CT images (minimum slice
thickness, 2 mm; maximum slice thickness, 5 mm; minimum in-plane resolution,
0.5625 mm/pixel; maximum in-plane resolution, 0.8789 mm/pixel) were obtained
with iodinated intravenous contrast injection prior to and after the ablation
procedure for tumor identification and for ablation zone assessment, respectively.
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The tri-phasic CT images that had been acquired at the time of recurrence
diagnosis were also obtained for the patients with biopsy-confirmed local
progression.
All of the imaging data were uploaded into an FDA-approved radiation
therapy treatment planning system (RayStation v5.0.2, RaySearch Laboratories,
Stockholm, Sweden). The liver was manually segmented on all portal venous
pretreatment, intraprocedural guidance, post-treatment, and recurrence CT
images. The venous phase of the pretreatment tri-phasic CT was used to delineate
the region of interest (ROI) of the gross tumor volume (GTV, as the contrast
between normal tissue and disease was greatest in this phase. The post-treatment
venous-phase CT image was used to define the ablation zone. The recurrent tumor
was defined on the venous-phase CT. Segmentations of the GTV, ablation zone, and
recurrent disease (as shown in Figure 31, Figure 32) were performed under the
guidance of a radiology-trained physician fellow and approved by a board-certified
diagnostic and interventional radiologist with 11 years of experience in
interventional radiology.
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Figure 31: Computed tomography (CT) scans from two patients are shown, one in the
left column and one in the right. (Top Row) Contouring of a colorectal liver
metastasis from diagnostic contrast-enhanced CT (red) and the liver contour (teal).
(Bottom Row) Contouring of the ablation region (orange on the left and dark blue on
the right) on the CT scan obtained immediately following the ablation.

Figure 32: Left: Post-treatment ablation image with the ablation zone contoured in
green. Right: Image from the same patient with recurrence contoured in blue. The
difference in ablation zone volume from post-treatment to recurrence is 50%.
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4.2.2 Biomechanical Modeling
Two different registration techniques were performed to map the disease
onto the post-treatment image in order to enable the calculation of the minimal
ablation margin. First, rigid registration was performed between pre-treatment
and post-treatment CTs using an automated gray-level cross correlation of the
liver volume ROIs. Second, the biomechanical model-based DIR algorithm Morfeus,
which is integrated with the RayStation system, was performed149,150 . Morfeus has
been shown to have an accuracy on the order of the image voxel size when
registering liver images for image-guided radiation therapy applications147,151 .
Morfeus creates triangular meshes of the surface of the liver. These define
the relationship between pre-treatment and post-treatment image sets. The
optimization of two mesh creation parameters in Raystation was investigated in
this study: the smoothing radius and the triangular-mesh edge length. We
investigated triangular mesh edge values of 3, 6, 9, and 12 mm (whereas the
default value is 6 mm) and smoothing radii of 1, 3, and 5 mm (whereas the default
value is 1 mm). The metric of success for our selection of these parameters was the
Dice similarity coefficient152 between the generated triangular mesh and the
manually defined slice-based contours on a patient-by-patient basis.
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The biomechanical liver model was then assigned a Young’s modulus of
1000 Pa and a Poisson’s ratio of 0.45, which represent stiffness and
compressibility, respectively, in a linear elastic material model. The
correspondence of the generated triangular mesh determined the boundary
conditions for the finite element analysis. The finite element analysis resulted in a
dense deformation vector field, which was resampled to the ROI of the liver
contour. The ablation zone was then propagated from the post-treatment to the
pre-treatment image set in two ways: using the results of the rigid registration
only and also using the deformation vector field.
4.2.3 Assessing Ablation Margin
With the disease contour mapped onto the registered post-treatment
imaging, a 3D minimum distance-to-agreement (DTA) was computed between the
GTV and the ablation zone following rigid registration alone and rigid registration
combined with biomechanical registration (as was shown in Figure 31). Regions in
which the ablation zone contour entirely encompassed the GTV were considered to
have positive ablation margins, and regions where the GTV and ablation zone
contour overlapped had a margin of 0mm. To remove bias of minimum margin
assessment when the GTV was on a subcapsular location, the ablation zone
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contour was expanded by 10 mm everywhere outside of the liver. This ensured
that the minimum margin was accurately recorded as the minimum margin within
the liver.
Comparison of rigid registration to deformable registration to distinguish
locally-recurring from non-locally-recurring patients was performed using a
Mann-Whitney U-Test153, as the data is not paired and not continuous since the
minimum DTA has a close limit of 0 mm.
4.3.4 Assessing Recurrence
To quantify the correlation of the 3D minimum margin with the location of
tumor progression, registration of the post-ablation image and the recurrence
image (which was obtained months later) is required, where physical changes in
the size of the ablation cavity challenge registration algorithms. Our data showed
an average decrease of 37% in ablation cavity volume from post-treatment to
recurrence images, which is likely due to dehydration of the tissue after thermal
ablation and autophagy of the treated tissue.
A rigid registration, rather than a deformable registration, was performed
to avoid the potential introduction of unknown errors, as there is no validated
deformable registration available to account for ablation zone shrinkage.
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A ray-tracing algorithm using spherical coordinates was used to assess the
correspondence of the recurrence to the 3D minimum ablation margin.
Comparison of spherical coordinates requires that the ablation zone in both the
post-treatment and the recurrence imaging be correctly registered both
translationally and rotationally. We developed a workflow to perform this focused
rigid registration of the ablation CT and follow-up CT based on the identification
and registration of vasculature in the normal liver in proximity of to ablation
region. While asymmetric shrinkage of the ablation zone in areas that are proximal
to large vessels is assumed, our rigid registration is driven by expecting the
similarities in the vessels to be robust to deviations in the ablation zone recovery.
The liver vasculature was automatically segmented using an in-house
developed vesselness algorithm154,155 on the post-treatment CT and the recurrence
CT. A sphere of interest with a radius of 5 cm, 7.5 cm, or 10 cm was defined on both
images, centered on the ablation zone in the post-treatment CT and the recurrence
CT. The rigid registration was then performed based solely on the vasculature
within these spheres of interest. The 7.5 cm radius was chosen on the basis of
visual inspection of the completed registrations for all patients.
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If sufficient vasculature could not be identified, manual registration was
performed to best align the ablation zones on the post-treatment and recurrence
images under the guidance of a trained interventional radiologist. To reduce bias,
the radiologist was unaware of where the predicted minimum margin was located.
To create a quantitative metric of the relationship between the identified
minimum margin on the post-treatment CT and the recurrence identified on the
follow-up CT, we developed a 3D ray-tracing algorithm to determine if the
spherical coordinates of the recurrence and the minimum ablation margin
matched. Figure 4 illustrates the ray-tracing process, in which a 3D cone was
created radiating from the center of the ablation zone on the recurrence CT, and
the cone intersected every point of the contoured recurrence. For visualization
purposes, this cone was then mapped onto the centroid of the ablation zone on the
post-treatment image. If the mapped cone overlapped the minimum margin, the
recurrence was considered to have occurred in the same relative region in which
the minimum margin existed. If the mapped cone did not overlap the identified
margin, the recurrence was considered to be unrelated to the minimum margin.
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4.3 Results
4.3.1 Assessing Ablation Margin
Rigid and deformable registrations between the pretreatment images and
both the intraprocedural and post-treatment images were successfully completed
for all 30 patients.
For the deformable registration, the mean (min-max, median) minimum
ablation margin around the GTV for patients without local recurrence was 3.19
mm (0.70-6.10, 2.90 mm), compared to patients diagnosed with local recurrence
where it was 1.14 mm (0-5.6, 0). Only three patients in the local recurrence group
had margins larger than 2 mm. A Mann-Whitney U test revealed a significant (P <
0.01) difference between the two groups based on the 3D minimum distance to
agreement. The data are tabulated in Table 2.
Table 2: Minimum Distance to Agreement (DTA) Between the Ablation Contour and
the Tumor Contour, % of GTV mapped volume and volume (cc) outside of ablation
zone, for Rigid and Deformed registration. Stratified Between Patients with Local
Recurrence and without Local Recurrence.
Patient ID
Local
Recurrence
1
2
3
4

Minimum DTA (mm)

% of GTV Volume
outside of ablation
zone

GTV Volume (cc)
outside of
ablation zone

Rigid

Deformed

Rigid

Deformed

Rigid

0.00
0.53
0.00
0.25

0.00
0.07
0.10
0.00

91.30
2.74
0.66
0.00

4.00
0.00
0.00
0.00

1.05
0.05
0.02
0.00

Deformed
0.25
0.00
0.00
0.00
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5
6
7
8
9
10
11
12
13
14
Mean
Standard Dev.
No Local
Recurrence
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Mean
Standard Dev.

0.00
0.24
0.00
0.00
0.00
0.00
0.00
0.00
0.10
0.00
0.08
0.15

0.05
0.00
0.00
0.47
0.00
0.17
0.00
0.00
0.00
0.24
0.08
0.13

24.95
16.90
2.39
18.07
70.96
11.68
17.10
68.01
0.00
11.09
23.99
28.96

0.00
0.58
3.47
0.00
17.65
0.00
0.21
12.01
0.00
2.50
2.89
5.20

1.03
0.52
0.03
0.56
1.58
0.21
0.57
3.99
0.00
0.18
0.70
1.03

0.00
0.01
0.04
0.00
0.37
0.00
0.01
0.48
0.00
0.05
0.09
0.15

Rigid

Deformed

Rigid

Deformed

Rigid

Deformed

0.40
0.00
0.27
0.00
0.17
0.10
0.15
0.00
0.24
0.00
0.07
0.00
0.00
0.20
0.00
0.00
0.11
0.12

0.60
0.61
0.24
0.48
0.20
0.45
0.28
0.30
0.45
0.52
0.24
0.07
0.14
0.20
0.30
0.00
0.34
0.17

49.16
100.00
0.00
2.72
0.00
0.00
0.00
35.24
0.00
41.19
0.00
0.00
14.10
0.00
2.32
4.86
15.60
27.04

0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.39
0.00
0.89
0.00
0.00
0.00
0.00
0.00
0.00
0.08
0.23

0.34
0.96
0.00
0.06
0.00
0.00
0.00
3.20
0.00
1.10
0.00
0.00
0.06
0.00
0.04
0.06
0.36
0.81

0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.04
0.00
0.03
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01

Rigid registration resulted in considerable errors in the mapping of disease,
where mapped disease was shown to overlap normal liver tissue. As the disease
and ablation zone will appear hypo-enhancing on portal venous phase imaging,
little to no amount of GTV volume mapped from the pre-treatment should be
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present outside of the ablation zone (barring small amounts due to any difference
in image sampling). We show the distribution of percentage GTV volume mapped
outside of the ablation zone (which should be essentially 0%) for both the rigid
and deformable registration in Table 2. The mean (standard deviation) of the
percentage GTV volume mapped outside of the ablation zone for rigid registration
was 19.51% (28.26%), while for deformable registration it was 1.39% (3.80%).
4.3.2 Assessing Recurrence
In two cases, the contrast enhancement was insufficient to identify any
nearby vasculature and so manual rigid registration was performed focused on the
ablation area. Of the 14 patients who experienced a recurrence, 13 (93%) had an
overlap of the recurrence and the 5-mm expansion of disease outside of the
ablation zone. That is, the recurrence occurred in the region where the ablation did
not cover the intended 5 mm margin around the tumor. The median volume of the
overlap between the projected cone and the minimum margin was 0.34 cc (range,
0-3.38 cc), as shown in Figure 33.
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Figure 33: Amount of volume overlap (cc) between projected recurrence cone and a 5
mm margin outside of ablation.
Despite the fact that the volume of overlap can be very small, the consensus
among our reviewing physicians is that the location of 5-mm expansion coincides
with actual recurrence as shown in Figure 34.
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Figure 34: Example of 5-mm expansion on post-treatment CT images (left column) vs
recurrence images (right column) for patient 5 and patient 14.
For patient #7, who did not have overlap, the definition of the ablation zone
post-treatment was not very clear, with the scan appearing to be in the arterial
phase rather than in the portal-venous, as shown in Figure 35.

80

Figure 35: Patient 7, where no overlap between the 5 mm margin and actual
progression was present. The poor contrast scan makes it difficult to identify where
exactly the boundary of sufficient ablation is located.

4.4 Discussion
The efficacy of this workflow was shown by distinguishing between the
patients who experienced local recurrence from those who did not with high
statistical significance using a Mann-Whitney U test (P < 0.01). We observed
overlap of future recurrence and the minimum ablation margin in 86% of patients,
and we believe this indicates that the minimum ablation margin is informative of
where recurrence might develop. Our study demonstrated that the mean
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difference in minimum ablation margin between the group of patients who
experienced local recurrence and the group who did not was large (2 mm, nearly
50% of the desired minimum margin for microwave therapy) and statistically
significant (P < 0.01).
Rigid registration alone was not sufficient to properly identify the minimum
ablation margin. In many cases, disease was mapped outside of the ablation zone
entirely when rigid registration was used as shown in Panel A of Figure 36. Most
notably, patient 2 in the local recurrence group was recorded as having a minimum
DTA of 5.3mm via rigid registration, which offered a false sense of confidence
compared to the result of the deformable registration shown in Panels B and C of
Figure 36.
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Figure 36: Failings of rigid registration. (A) Rigid registration of the gross tumor
volume (GTV, red) onto the post-ablation CT maps part of the tumor outside of the
ablation zone (green) and gives a false sense of confidence in the delivered margin
caudally. (B) Deformable registration of the GTV (gold) onto the post-ablation CT
indicates potentially insufficient ablation margin in the caudal aspect. (C)
Development of disease progression (pink) in the caudal aspect of the recovered
ablation zone (green) corresponds to the insufficient margin in (B).
The proposed workflow has the potential to improve local control rates in
patients by assessing the minimum DTA immediately following ablation even in
cases in which the deformation exceeds 1 cm. The development of deep learning
for liver segmentation has removed the previous challenges in clinical
implementation introduced by manual segmentation74 . The process is fully
automated after receiving segmentations of the GTV, ablation zone, and liver. It
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runs in approximately 5 minutes. The result returns the ablation margin on the
pretreatment image and an image showing the distribution of the ablation zone.
This distribution can assist the physician during the procedure in identifying
where further ablation may be desired. Previous work has shown that ablation
assessment can reduce local progression rates, but it required a secondary ablation
procedure156 .
In addition to determining the ablation margins, the algorithms that were
investigated in this research can also be employed to ensure accurate placement of
the probe into the tumor, especially in cases where contrast is no longer present in
the image and artifacts from the ablation probes themselves impair tumor
visibility. This would require a CT scan of the entire liver once the probe is inserted
to perform biomechanical model-based DIR to map the tumor onto the image with
the probe to evaluate accuracy of placement.
Our work is primarily limited by the paucity of patients presenting with
CLM who also had had contrast-enhanced CT scans performed within 45 days of
treatment and also post-treatment scans on the day of treatment. The amount of
volume overlap between recurrence and volume of tissue within the 5-mm margin

84

that was not covered by the ablation region also was small. It was less than 0.5 cc
for 61% (8/13) of the patients in whom overlap was present. However, it is
important to note that we expect that the overall volume of tissue that should have
been included in the 5 mm ablation margin volume, but was not (i.e. the area of
missed ablation) would be very small, and therefore any overlap would also be
small. However, it also demonstrates the importance of achieving a complete 5 mm
ablation margin volume around the tumor.

4.5 Conclusions
Our work demonstrates the potential utility of a biomechanical modelbased DIR to aid in determining if a sufficient ablation margin has been achieved
and correlating the location of the recurrence to the minimum ablation area. For
ease of use, we have created a GUI built into our treatment planning system which
automates a majority of the process as shown in Figure 37. The clinical impact of
these tools is currently being evaluated in a randomized phase II clinical trial.
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Figure 37: Graphical user interface (GUI) created to facilitate workflow process.
Users will select the pre-treatment (primary) CT, post-treatment (secondary) CT,
boundary, GTV, and ablation ROI. Method is deformable or rigid.
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Chapter 5: Deep learning autosegmentation of liver
structure: liver, disease, ablation zone, and liver lobes
The goal of this chapter is to address specific 2.2.2 Specific Aim 2: Creation
of a deep learning neural network to delineate the liver structure, metastatic
tumor, and ablation zone.

5.0 Segmentation of the liver
The ability to rapidly and robustly segment the liver on variable contrast
imaging is one of the most vital parts in creating a clinically feasible system for our
work. The creation of the deformation vector field relies on accurate
segmentations of the liver to serve as boundary conditions for the creation of the
triangular mesh as shown in Figure 38.

Figure 38: Middle: Generated controlling triangular mesh used for biomechanical
modeling. The creation of which requires (left) segmented liver on Pre-Treatment
imaging and (right) segmented liver on Post-Treatment imaging.
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The manual contouring of the liver can take up to 30 minutes

157,158 , and

variations in segmentation of the liver from pre-treatment to post-treatment can
adversely affect the DIR. In order to ensure reproducibility in segmentation, we
required a method of rapidly and consistently segmenting the liver.
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5.0.1 Abstract
Purpose
The deformable nature of the liver can make focal treatment challenging
and is not adequately addressed with simple rigid registration techniques. More
advanced registration techniques can take deformations into account (e.g.,
biomechanical modeling) but require segmentations of the whole liver for each
scan, which is a time-intensive process. We show that fully convolutional networks
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can be used to rapidly and accurately autosegment the liver, removing the
temporal bottleneck for biomechanical modeling.
Methods and Materials
Manual liver segmentations on computed tomography scans from 183
patients treated at our institution and 30 scans from the Medical Image Computing
& Computer Assisted Intervention challenges were collected for this study. Three
architectures were investigated for rapid automated segmentation of the liver:
VGG-16, DeepLabv3 +, and a 3-dimensional UNet. Fifty-six cases were set aside as a
final test set for quantitative model evaluation. The accuracy of the
autosegmentations was assessed using the Dice similarity coefficient and the mean
surface distance. A qualitative evaluation was also performed by three radiation
oncologists on 50 independent cases with previously clinically treated liver
contours.
Results
The mean (minimum-maximum) mean surface distance for the test groups
with the final model, DeepLabv3 +, were as follows: μContrast(N = 17): 0.99 mm (0.472.2), μNon_Contrast(N = 19): 1.12 mm (0.41-2.87), and μMiccai(N = 30): 1.48 mm (0.82-3.96).
The qualitative evaluation showed that 30 of the 50 autosegmentations (60%)
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were preferred to manual contours (majority voting) in a blinded comparison, and
48 of the 50 autosegmentations (96%) were deemed to be clinically acceptable by
at least one of the three reviewing physicians.
Conclusions
The autosegmentations were preferred compared to manually defined
contours in the majority of cases. The ability to rapidly segment the liver with high
accuracy that was achieved in this investigation has the potential to enable the
efficient integration of biomechanical model-based registration into a clinical
workflow.
5.0.2 Introduction
The treatment of primary and secondary liver cancers normally involves
surgery, chemoembolization, ablation, or external beam radiation therapy (RT),
and requires 3-dimensional (3D) imaging, either computed tomography (CT) or
magnetic resonance imaging. Specifically for RT, segmentation of the liver on CT
imaging is required for treatment planning. More complex RT treatment regimens
may include additional CT imaging for dose escalation and plan adaptation. Owing
to the deformable nature of the liver, simple rigid registration techniques are
suboptimal for 3D dose tracking. Biomechanical model-based deformable image
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registration have been shown to accurately model the deformation of the
liver149,150 , but these methods require segmentations of the whole liver as the
controlling region of interest. Thus, segmenting the liver in a consistent manner is
particularly important. Manual contouring of the liver can take up to 30
minutes157,158 , and in the case of biomechanical models, inter- and intraoperator
contour variations may adversely affect the deformable image registration.
Fully convolutional networks (FCNs) have shown great promise in
accurately segmenting 2D and 3D images with multiple classes in very short
amounts of time88,89,91,159,160 . FCNs have been shown to accurately contour the liver
in contrast-enhanced CT images161 , but less work on noncontrast CT images has
been reported. When assessing the feasibility of these FCN models, Dice similarity
coefficient (DSC) scores or volume differences are often reported as the sole
metric. Unfortunately, such metrics can be relatively insensitive to erratic edge
segmentations that would not be acceptable for clinical use, yet they achieve a high
score. For example, for the mean surface distance (MSD) metric, the sheer number
of images that are present in a CT scan can result in a low value while hiding
potentially clinically impactful errors. Therefore, the work described herein
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includes both quantitative and separate qualitative (blinded physician
comparison) analyses of the results to determine actual clinical feasibility. We
hypothesized that FCNs can be used to rapidly and accurately contour the liver on
both contrast- and noncontrast-enhanced CT with minimal disruption of the
treatment workflow.
5.0.3 Materials and Methods
Data
For this retrospective work, 155 consecutively acquired patients from our
institution (The University of Texas MD Anderson Cancer Center) were collected
under an institutional review board–approved protocol and 30 image sets were
obtained from the Medical Image Computing & Computer Assisted Intervention
(MICCAI) multiatlas challenge (data:
https://www.synapse.org/#!Synapse:syn3193805/wiki/89480).
Contrast-enhanced computed tomography scans
Of the 155 consecutive patients from our institution, 62 patients had
received intravenous contrast CT using a quadriphasic protocol, enabling the
visualization of the tumor and vasculature within the liver. The images had pixel
spacing ranging from 0.5625 mm to 1.27 mm and slice thickness from 1.5 cm to 5
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cm. For this cohort of patients, manual segmentations of the liver were defined on
both scans by a graduate student (BMA) under the guidance, evaluation, and
approval of a board-certified interventional radiologist (BCO) with expertise in
treating cancers in the liver. Forty-two patients had multiple CT images and when
this occurred, the patient images were kept within the training group. In total,
there were 108 contrast-enhanced CT examinations.
Non-Contrast computed tomography scans
The remaining 93 patients’ CT scans were without contrast injection and
are different patients than from the original contrast-enhanced CT cohort. These
noncontrast CT scans were included in the training set to create a more robust
model that could identify the liver in both contrast and noncontrast images. We
found that creating a model using contrast images alone provided similarly high
DSC scores on the test set (μ = 0.96; σ = 0.02), but inspection of the noncontrastenhanced images often showed oversegmentation, including the heart, and
undersegmentation when near a disease site. Therefore, we deemed including
contrast and noncontrast image sets to be necessary. Three patients had multiple
examinations, and for them, the patient images were kept in the training cohort. In
total, there were 97 noncontrast-enhanced CT examinations. Fifty-three of these
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image sets had previously defined manual contours, which were visually evaluated
and edited when that was deemed to be necessary. The contours for the remaining
44 image sets are explained in the data preparation section.
Training/Validation Data
Seventy-two institutional contrast-enhanced CT image sets and 63
institutional noncontrast CT images were randomly selected from the data cohort
as training sets, resulting in a total of 135 images. We ensured that all 42 patients
with multiple examinations appeared solely within the training set (i.e., there was
no overlap among the training, testing, and validation sets). Nineteen contrastenhanced CT images and 15 noncontrast CT image sets were randomly selected as
a validation set to optimize the model parameters.
Test Data
A test set of 66 images was assembled. It was composed of 30 MICCAI
abdomen challenge image sets along with 19 noncontrast-enhanced and 17
contrast-enhanced institutional image sets. These patients were never seen in
either the training phase or the validation phase of the model. A breakdown of the
data and distribution of images across training, testing, and validation is shown in
Table 3.
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Table 3: Data distribution. Note that all patients with multiple exams were kept in
the training set.
Distribution (Images)
DataSet

Npatients

NImages
Train

Validation

Test

Contrast

62

108

72

19

17

Non-Contrast

93

97

63

15

19

MICCAI

30

30

0

0

30

Abbreviation: MICCAI = Medical Image Computing & Computer Assisted
Intervention.
These images were acquired on a variety of scanners with varying imaging
protocols. A summary of the imaging parameters of all of the data is shown in
Table 4.
Table 4: Acquisition average and median values of kVp, exposure time, slice thickness,
and pixel spacing across the training, testing, and validation groups.
Group

kVp

Exposure Time (ms)

Slice Thickness (mm)

Pixel Spacing (mm)

Mean

Median

Mean

Median

Mean

Median

Mean

Median

Training

121

120

1050

912

3.4

2.5

0.85

0.81

Validation

120

120

953.5

800

3.125

2.5

0.88

0.8

Testing

121

120

1070

920

3.11

2.5

0.83

0.75

All patients with multiple examinations were kept in the training set.

96

Architecture
We investigated three architectures, two of which are two-dimensional (2D)
and built upon the ideas of transfer learning (i.e., taking a previously trained
network and maintaining some of the abstract concepts for a new identification
task), and one 3D UNet style architecture. The pretrained networks were trained
on nonmedical images and then applied to our segmentation task. First, we
investigated a 2D UNet style architecture built on top of the Visual Geometry Group
(VGG)–16 net,85 where 16 refers to the number of convolutional and fully
connected layers. The VGG network was originally created to classify images from
more than 1000 classes (e.g., dog, cat, and car). These images are nonmedical, but
the features that are learned by the early layers are often abstract and can be
useful to other tasks.
Studies have shown that algorithms that have been pretrained on
nonmedical images improve the segmentation accuracies on medical images162 .
Long et al adapted the VGG-16 architecture for pixel-wise segmentation by
including transpose convolutions and skip connections88 . For our architecture, we
used bilinear upsampling in lieu of transpose convolutions to help mitigate the
issue of the checkerboard artifact (https://distill.pub/2016/deconv97

checkerboard/) and added concatenation layers. The VGG-16 architecture was
investigated because its reduced number of parameters increases its training and
prediction efficiency. Long et al. had similarly found negligible differences between
the VGG-16 and -19 architectures.
Second, we investigated the Deeplabv3+ network with an implementation
in TensorFlow, facilitated by the work presented here
(https://github.com/bonlime/keras-deeplab-v3-plus). This network benefits from
the robustness of spatial pyramid pooling and the sharp lines that are achieved
from the encoder-decoder setup. Contrary to most encoder-decoder architectures,
this saves memory by implementing only a single skip layer. Our code varies
slightly from the original implementation in that all of the ReLU activations were
converted to ELU activations and the dropout was removed, which helps to
remove some of the model instability that is seen in training.
Lastly, we investigated a 3D UNet style architecture with and without atrous
convolutions and residual and skip connections. We investigated varying numbers
of layers from two to five, the number of atrous convolutions, and the number of
initial and maximum filters.
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Data Evaluation
Quantitative
The accuracy of the liver autosegmentation algorithm, compared to that of
manual segmentation, was determined based on two metrics: the Dice similarity
coefficient (DSC), which is defined in equation (1), and the mean surface distance
(MSD). A paired Student’s t-test was performed among the three models run on the
test data to evaluate the ‘best’ final model.
𝐷𝑆𝐶 = 2

𝐴∩𝐵
𝐴+𝐵

(1)

Qualitative
A second, completely independent set of 50 patients (25 hepatocellular
carcinoma [HCC] and 25 colorectal liver metastases [CLM]) who had received RT at
The University of Texas MD Anderson Cancer Center and had clinically-defined and
-approved manually delineated contours of the liver, was also obtained. A group of
three radiation oncologists who are experienced in treating liver cancer (EK, GS,
PD) were asked to blindly rate the generated contours versus the previously
manually-defined and approved clinical contours. The clinically-defined and peerreviewed contours had been created by the gastrointestinal radiation oncology
group at our institution, which included the three radiation oncologists who
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performed the comparisons. One of the radiation oncologists reviewed all 50
patients twice, with a 4-month gap between reviews to reduce repeat bias.
The first blinded review was performed by each physician alone and the
second was done as a group. Both the previous manually drawn contours and the
automatically generated contours were randomly named either A or B and
assigned a random color for comparison. The images and both contours were
displayed without identifying the contour source in a RT treatment planning
system (Raystation v6, Raysearch Laboratories, Stockholm, Sweden). The contours
were judged based on two criteria: whether or not there was a preference for one
contour over the other, and whether or not the contours were acceptable for
immediate clinical use 1) without any editing, 2) needing only minor editing, or 3)
needing major editing. The physicians specified that minor edits were contours
where two to four slices would need editing and major edits where either five or
more slices needed editing or a clinically important part of the liver was not
included. For the comparison, we first investigated if any of the three radiation
oncologists believed that the contours were immediately clinically usable for RT
planning. Then, we performed majority voting for each patient.
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Training
Data Preprocessing
All of the images were normalized using the mean (ie, 80) and standard
deviation (SD; ie, 42) of the liver as found across the images in the training data
set. Each image was normalized by subtracting the mean and dividing by the SD.
Initial Optimizing
Training and validation were performed using TensorFlow 1.15.214 within
Python. The Texas Advanced Computing Center, which incorporates a 16 GB Tesla
K40 GPU, was used to facilitate the process of creating a model. The final training
was performed on an in-house system containing a 16 GB NVIDIA Quadro P5000
GPU with 24 CPU cores (3 GHz).
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Data Preparation
Owing to the smaller number of noncontrast CT images compared to the
number of contrast-enhanced CT images, an initial model was trained on the
available images and used to generate new contours on the remaining 44
noncontrast image sets. These generated contours were manually edited to ensure
an accurate final contour of the liver. With the new images, the model was
retrained from the ground up. These training patients were not included in the test
set.
Parameter Search
Learning rates for models can have a substantial impact on model
performance. Learning rates that are too high lead to overfitting on the training
set, while rates that are too low prevent the model from reaching a stable solution.
We identified the minimum and maximum learning rates using our own adaptation
of the learning rate finder (https://www.pyimagesearch.com/2019/08/05/keraslearning-rate-finder/). This was done for each version of the 3D model and for the
VGG16 and v3Plus models. The Adam optimizer with categorical cross entropy loss
function was used across all three architectures.
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To identify the best of the various iterations of architectures in the 3D
model, each architecture was trained for 40 epochs, the point at which the
performance appeared to plateau. The statistical package R was then used to plot
the validation loss, looking for trends that might indicate if more or fewer layers or
filters would result in improved performance and ensure that we were searching
within a useful range (i.e., if the loss was decreasing with increasing layers, we
would want to investigate adding more layers until the loss increased, as shown in
Figure 39). For the final training, each model was trained for 100 epochs, or until
its performance on the validation set plateaued.

Figure 39: Hyper-parameter searching for ideal UNet style architecture. Parameters
varied were number of layers in depth (2-5), number of convolution layers (0-2)
versus atrous layers, and maximum number of filters (16-32). For ease of viewing,
convolution layer 2 is not shown.
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Confidence Threshold
The probability cutoff for the model to distinguish the liver from the
background on a voxel-by-voxel basis was investigated in the range from 0.05 to
0.95 in 0.05 increments for each model. The cutoff was decided for each model
independently of the others based on the validation set by finding the maximum
Dice similarity coefficient. The output Dice similarity coefficientappeared to trend
similarly between the contrast and noncontrast cases, and so a single cutoff was
chosen to allow for the model to predict on any liver without regard to the
presence or absence of contrast, as shown in Figure 40. Any pixel with a
probability of being in the liver that was greater than the cutoff was added to the
binary output mask. Because the liver is a single continuous organ, an automatic
step was implemented to remove all but the largest continuous binary structure.

104

Figure 40: Dice Similarity Coefficient vs threshold for prediction on the VGG16 model.
Note how the contrast and non-contrast groups both follow the same general trend
and prediction threshold maximum.
Qualitative Continuity
The qualitative evaluation of 50 patients, which required a significant
amount of physician users’ time, was performed using the prediction model that
had been trained on data including the MICCAI challenge data. To determine
whether or not the newly trained model was equivalent to the original one and the
qualitative results would hold for the new model, we performed a MSD comparison
between the contours generated from the original and final DeepLabV3+ predicted
liver models.
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5.0.4 Results
The prediction cutoffs based on the validation data for the VGG16, v3Plus,
and 3D models were found to be 0.4, 0.3, and 0.3, respectively. With these cutoffs,
the three models were used to predict on the 63 test sets of CT images (33 of which
were institutional and 30 were from MICCAI). The volumetric comparisons (DSC
and MSD) between the predicted and ground-truth volumes for these patients are
summarized in Table 5 and Table 6. The MSD mean (minimum-maximum) were
contrast (n = 17): VGG16: 1.25 mm (0.60-2.95), V3Plus: 0.99 mm (0.47-2.2),
3DUNet: 4.66 mm (2.35-13.88); Noncontrast (n = 19): VGG16: 1.37 mm (0.692.93); V3Plus: 1.12 mm (0.41-2.87), 3DUNet: 5.20 mm (1.94-17.92); and MICCAI (n
= 30): VGG16: 1.80 mm (0.65-7.02), V3Plus: 1.48 mm (0.82-3.96), and 3DUNet:
5.15 mm (3.08-9.07).
Table 5: Test Results by group for each model in Dice Similarity Coefficient.
Mean(min,max)
Test Data

Dice Similarity Coefficient
Model Name

Data Set

N_Images

Contrast

17

Non-Contrast

19

MICCAI

30

3D Unet
0.87
(0.72, 0.92)
0.86
(0.74, 0.93)
0.85
(0.74, 0.91)

VGG_16
0.96
(0.93,0.97)
0.95
(0.91, 0.97)
0.95
(0.90, 0.97)

V3_Plus
0.96
(0.95, 0.98)
0.96
(0.91, 0.98)
0.95
(0.90, 0.97)
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Table 6: Test Results by group for each model in Mean Surface Distance (mm).
Mean(min,max)
Mean Surface Distance (mm)

Test Data
Data Set

N_Images

Contrast

17

Non-Contrast

19

MICCAI

30

3D Unet
4.66
(2.35, 13.88)
5.20
(1.94, 17.92)
5.15
(3.08, 9.07)

Model Name
VGG_16
1.25
(0.60, 2.95)
1.37
(0.69, 2.93)
1.80
(0.65, 7.02)

V3_Plus
1.02
(0.46, 1.89)
1.18
(0.41, 3.21)
1.54
(0.90, 3.68)

A paired t-test between the VGG16 and V3Plus models found the V3Plus
model to be significantly better (P = 1e-6), and a paired t-test between the V3Plus
model and the 3DUnet found the V3Plus to be significantly better (P = 1e-27). We
suspect that the predictions on the contrast-enhanced images are better than those
on the noncontrast scans in the case of the 2D models because the major failings of
the 2D models are where the segmentation goes too far inferior into the bowel.
With contrast, differentiation between the liver and the bowel is easier. In the 3D
model, the contrast-enhanced scans actually appeared to do worse; the model
appeared to arbitrarily exclude part of the liver from the segmentation. Predictions
overlayed onto CT scans are shown for the median and worst case for each
architecture in Figure 41. Box plots showing the results (DSC, MSD, and Hausdorff
distance) of each model for each group are presented in Test Results by Model.
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Figure 41: Predictions (red) overlayed on top of computed tomography scans for
median and worst cases for each architecture. Red arrows indicate regions of failure.
A summary of the qualitative results of the V3Plus model prediction is
shown in Table 7. In 41 of the 50 cases (82%), at least one physician preferred the
automatically-generated contours to the clinically-drawn contours. In 48 of the 50
cases (96%), at least one radiation oncologist deemed the automatically generated
contours to be immediately clinically usable.
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Table 7: Consensus model results for the three reviewing radiation oncologists.
Reviewer 1 reviewed all cases twice with a four-month interval between the first (1a)
review and the second (1b). Majority voting means that at least two of the three
reviewers agreed on a case-by-case basis, and ties were split. At least 1 means that at
least one reviewer voted in the manner listed. *Values of 0.5 were split ties.

Reviewers

1a, 1b, 2, 3

1b, 2, 3

Majority or
one?

Preference

Clinically Usable

Minor Edits

Major Edits

Auto

Manual

Auto

Manual

Auto

Manual

Auto

Manual

Majority
Voting

60%
(30/50)

40%
(20/50)

81%*
(40.5/50)

89%*
(44.5/50)

33%*
(16.5/50)

45%*
(22.5)

19%*
(9.5/50)

11%*
(5.5/50)

At least 1
vote

82%
(41/50)

64%
(32/50)

96%
(48/50)

100%
(50/50)

86%
(43/50)

96%
(48/50)

58%
(29/50)

52%
(26/50)

Majority
Voting

62%
(31/50)

38%
(19/50)

76%
(38/50)

82%
(41/50)

42%
(21/50)

50%
(25/50)

24%
(12/50)

18%
(19/50)

At least 1
vote

76%
(38/50)

64%
(32/50)

88%
(44/50)

96%
(48/50)

76%
(38/50)

88%
(44/50)

58%
(29/50)

52%
(26/50)

The two cases that were deemed not to be clinically usable are shown in
Figure 42. Compared to the manual segmentations, the automatically generated
segmentations were preferred in 32 of 50 cases (64%) upon visual inspection. The
V3Plus predictions were created in a median time of shorter than 0.1 second per
slice or approximately 9 seconds for a 90-slice image scan on both contrast and
noncontrast livers on a 16GB GPU computer.
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Figure 42: (A) Presence of a high-contrast biliary stent causing autosegmentation to
underestimate liver, requiring editing, and (B) ascites misidentified as liver. Teal:
ground truth; red: autosegmentation.
The difference between the V3Plus model used for qualitative evaluation
and the final optimized V3Plus model, excluding the patients who needed major
editing (e.g., the liver ascites and stent cases, which were also not usable in the
new model), was a median MSD of 1.02 mm (SD = 0.41) with a maximum MSD of
2.2 mm.
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Test Results by Model
Dice Similarity Coefficient

Figure 43: Dice Similarity Coefficient for predictions on test set by Deeplab v3+ model
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Figure 44: Dice Similarity Coefficient for predictions on test set by VGG16 model

Figure 45: Dice Similarity Coefficient for predictions on test set by 3D UNet model
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Mean Surface Distance

Figure 46: Mean Surface Distance for predictions on test set by Deeplab v3+ model
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Figure 47: Mean Surface Distance for predictions on test set by VGG16 model

Figure 48: Mean Surface Distance for predictions on test set by 3D UNet model
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Hausdorff Distance

Figure 49: Hausdorff Distance for predictions on test set by Deeplab v3+ model
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Figure 50: Hausdorff Distance for predictions on test set by VGG16 model
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Figure 51: Hausdorff Distance for predictions on test set by 3D UNet model
5.0.5 Discussion
This work presents a comparison of three state-of-the-art automatic
segmentation methods for the liver with the addition of more informative,
qualitative metrics of segmentation efficacy. A potential limitation is that the twodimensional algorithm would not include large disease present on the boundary of
the liver. Incorrect segmentation was often due to the 2D model’s difficulty in
identifying the most inferior aspects of the liver, where a small liver size could
cause the model to undersegment or continue onward into the bowel. The main
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failure of the 3D model was undersegmenting the liver in certain patients. A better
view of each model’s failures can be seen in the worst case for each architecture, as
shown in Figure 41. A comparison of our results to those in the recent literature is
shown in Table 8.
Table 8: Comparison of present method to recent liver segmentation methods
Method
Present

Source

Test Size

Dice

Contrast

17

0.96

Non-Contrast

19

0.96

MICCAI

30

0.95

Contrast

20

0.94

Contrast

127

0.96

Non-Contrast

13

0.96

2016

159

2017

160

2017

163

Contrast

150

0.95

2017

164

Contrast

7

0.94

2018

102

Contrast

129

0.95

Contrast

20

0.94

A variety of automatic liver segmentation architectures have been
investigated with promising results

79,102,160,164,165 from a variety

of methods (such

as cascaded 3D, pretrained 2D networks, and residual networks), but there has
often been no inclusion of human elements to validate the efficacy of the model
segmentations. Only our method includes the qualitative assessment of the created
liver segmentation compared to previous clinical segmentations. This is

118

particularly important in the liver where the size of the organ makes volume
metrics, such as DSC, insensitive to potentially clinically important missegmentations. Note that the two cases that were deemed not to be clinically
usable (Figure 42) had DSC scores of 0.94 and 0.72.
The combination of a cascaded UNet with 3D conditional random fields 78
showed positive results (0.94 DSC) in segmenting the liver on contrast-enhanced
images, but was limited to a 20-patient test set, of which 15 patients (75%) had
HCC. A unique system of a 3D convolutional neural network for an initial
probability map, followed by probability density function refinement

166 , was

presented with similar DSC scores for both contrast and noncontrast image scans;
however, those results were from a 5-fold cross validation of abdominal CT scans
and not a withheld test set. A multiorgan abdominal segmentation 3D FCN163
presented results from training on 281 contrast-enhanced CT scans, and an
external test set of 150 contrast-enhanced CT scans from another hospital, with a
mean Dice score of 0.954. That created model was able to segment the liver,
spleen, and pancreas, but it does not include noncontrast segmentation
capabilities. A combination of axial, sagittal, and coronal 2D views combined with
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2D FCNs and voxel-based voting, showed the benefits of 3D information but with
2D efficiency; however, the withheld data set was limited to seven contrastenhanced CT patients. The method by Roth et al 102 used a unique multiscale
pyramid 3D FCN with two image resolution sizes and Dice coefficient loss. This
architecture was able to segment multiple organs and to produce segmentations
similar to those presented by our own algorithm, but it is limited to contrastenhanced CT scans.
All of the reviewing radiation oncologists agreed that 2 of the 25 patients
with HCC whole liver contours required major editing due to the algorithm’s
difficulty in identifying the liver around the disease site. An investigation into these
two cases requiring major editing by qualitative assessment (Figure 42) showed
that in case A, the segmentation was cut off on some slices due to the biliary stent,
and in case B, the algorithm had difficulty distinguishing between the liver and
ascites. There were no cases with stents or ascites in the training set. We
hypothesize that including more patients with these characteristics in the training
set could improve the model’s ability to accurately autosegment the livers for these
types of patients; however, this needs to be further investigated. Between the two
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patient cohorts (25 HCC and 25 CLM) of the qualitative data, 25 of 25 patients with
CLM (100%) automatic contours were deemed by at least one reviewing physician
to be clinically usable without the need for any editing.
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5.1.0 Abstract
Background
Colorectal cancer (CRC), which is the third most common cancer in the USA,
is a leading cause of cancer-related death worldwide. Up to 60% of patients
develop liver metastasis (CRLM). Treatments like radiation and ablation therapies
require disease segmentation for planning and therapy delivery. For ablation,
ablation-zone segmentation is required to evaluate the disease coverage. We
present a fully convolutional (FC) model to segment CRLM and ablation-zones.
Purpose
We hypothesize that FC neural networks that have been trained using novel
methods will provide rapid and accurate identification and segmentation of CRLM
and ablation-zones.
Materials and Methods
Four FC model styles were investigated: Standard-, Residual-, Dense-3DUNet, and Hybrid-WNet. These models were trained on 92 patients from the Liver
Tumor Segmentation (LiTS) challenge. For the evaluation, we acquired 15 patients
from the 3D-IRCADb database, 18 patients from our institution (CRLM=24,
ablation-zone=19), and submitted to the LiTS challenge (n=70).
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Qualitative evaluations of our institutional data were performed by two
board certified radiologists (one interventional, and one diagnostic), and a
radiology-trained physician fellow using a Likert scale from 1-5.
Results
The most accurate of the models that were considered was the HybridWNet. On a patient-by-patient basis in the 3D-IRCADb dataset, the median (minmax) Dice similarity coefficient (DSC) was 0.73 (0.41-0.88), median surface
distance was 1.75mm(0.57–7.63mm), and number of false-positives was 1 (0-4). In
the LiTS challenge (n=70), the global DSC was 0.810. The model sensitivity was
98% (47/48) for sites that were more than 15 mm in diameter. Qualitatively,
100% (24/24; minority vote) of the CRLM and 84% (16/19; majority vote) of the
ablation-zones had Likert scores of 4 or 5.
Conclusion
The Hybrid-WNet model provided fast (less than 30 seconds) and accurate
segmentations of CRLM and ablation-zones on contrast-enhanced CT scans with
positive physician reviews.
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5.1.1 Introduction
Colorectal cancer (CRC) is the third most common cancer in the United
States in both men and women17 and a leading cause of cancer-related death
worldwide123 . Up to 60% of patients will develop colorectal liver metastasis
(CRLM) over the course of their disease, and 25% present with CRLM at the time of
their initial diagnosis16 . Moreover, it is believed that liver involvement with CRLM
is the main determinant of survival in this patient population. Such facts highlight
the importance of liver-directed loco-regional therapies (LRT) for the management
of these patients.
While several treatment options are available for CRLM (in particular
radiation and ablation therapies), they all rely on an accurate estimation of the
disease extent, which is usually based upon cross-sectional imaging with contrastenhanced CT (CECT) or MRI. CRLM often appears as hypo-enhancing lesions on
routine CECT portal-venous phase images. However, their detection can be
challenging due to ill-defined margins, particularly for sub-centimeter lesions.
Both radiofrequency and microwave ablation interventions aim for a
minimum margin to be delivered around the gross disease to ensure that all of the
microscopic disease is treated. This requires both the segmentation of disease on
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pre-treatment images and the delineation of the ablation zone on post-treatment
images to assess the final delivered ablation margin167 . The ablation zone is hypoenhanced on CECT images, similarly to the CRLM. A clinical trial is underway
(Identifier: NCT04083378) to map the CRLM from pre-treatment to posttreatment imaging and assess treatment efficacy, but manual segmentations of
both the disease and the ablation zone are still required168 , adding time to the
procedure.
To date, automated liver disease segmentation tasks have either focused
primarily on primary liver disease or have not included a qualitative evaluation of
the generated contours98,99,159,169. New institution- and society-sponsored
competitions, such as the Liver Tumor Segmentation (LiTS) Challenge170 and the
3D-IRCADb01159 dataset have included data from both primary and secondary
liver cancers, thereby enabling investigation, development and comparison of
automatic segmentation algorithms using public data.
We hypothesized that fully convolutional neural networks that had been
trained using novel methods to account for the challenges of varying disease size
would provide rapid and accurate identification and segmentation of both CRLM
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and ablation zones. We believe that this approach will facilitate the automated
detection of CRLM, the planning of radiation treatment for CRLM, and the
evaluation of the treatment margin in ablation therapy.
5.1.2 Materials and Methods
Data
To ensure reproducibility by other institutions, we generated a fully
convolutional neural network using data that were provided by the publicly
available LiTS challenge170 . The LiTS dataset consists of CECT scans of 131 patients
with primary liver tumors and secondary liver metastasis. Ground truth
segmentation of the liver and disease were provided by the challenge, although
only the disease segmentations were used in this study. Each image and disease
segmentations was reviewed by BMA to remove the data showing hyperenhancing metastases, a lack of CRLM, or an absence of image acquisition
parameters (e.g. slice thickness, pixel spacing). A total of 92 patients remained, of
which 72 were used for training and the other 20 for validation.
We evaluated our model via submission to the LiTS challenge (70 patients),
and via evaluation of the 3D-IRCADb01 publicly available dataset171 . Table 1 shows
the image acquisition parameters for the training, validation, and test sets. Five of
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the patients from the 3D-IRCADb01 dataset were excluded: patients 5, 11, and 20
had no CRLM, patient 12 had a large cystic lesion at the base of the liver, and
patient 18 had CRLM with an atypical enhancement pattern.
Pre-Processing
Image Intensity Alteration
Initial attempts to normalize the data on the basis of the global mean and
standard deviation resulted in extreme outliers when the contrast within the liver
was high or low relative to the global mean. To best separate the normal tissue
from the disease, we calculated a patient-specific mean and standard deviation on
the basis of the Full-Width-Half-Max of the histogram of the pixel values within the
provided contoured liver. As a result, the disease consistently appeared darker
than the normal tissue. The image intensity outside of the masked liver was set to
be equal to 0 after normalization.
Voxel Size Resampling
To account for the sensitivity of convolutional neural networks to varying
image sizes and resolution, we resampled all training and validation images to a 1
mm slice thickness using bi-linear interpolation. Likewise, we applied bi-linear
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interpolation to the ground-truth segmentations of the disease, providing the
model with values of 0-1 for each part.
Training Image “Slabs”
Smaller structures are inherently “worth less” than larger structures when
categorical cross-entropy is used as a loss function and class weighting is not
applied. To account for disparities in class representation, we distributed our
training into unique “slabs”. Simple class weighting would not solve this problem
as it would result in the modeling weighing heavily diseased cases as more
important to learning than the less diseased cases. Each independent disease site
was divided into individual “cubes” of 32x120x120 voxels, as shown in Figure 52.

Figure 52: Liver distributed into individual slabs of 32x120x120. Disease was labeled
as disease, regardless of the center of the slab. The validation and test set were not
broken into slabs; our architectures accepted variable input sizes as a fully
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convolutional network, with the entire liver being passed at once for evaluation and
testing.
The slabs were extracted sequentially, with large disease sites being broken
up into multiple cubes. Every slab had disease present within it. After extraction,
the training dataset consisted of 572 unique image slabs that were shuffled
randomly.
Unlike for the training data, the validation and test sets were are not broken
into cubes. Our fully convolutional architectures accepts variable input size, with
the entire liver being passed in at once for evaluation and testing.

Architectures
Four architectures were investigated: Standard 3D UNet, Residual 3D UNet,
Dense 3D UNet, and Hybrid-WNet (a hybrid pre-trained Standard 2D UNet
combined with a 3D DenseUNet). The basic architectural framework (i.e., the
number of convolution blocks per layer, the number of layers, the convolution
block lambda [i.e., the increase in the number of convolution blocks per layer], and
the maximum number of convolution blocks) remained the same for the Standard,
Re5sidual, and Dense 3D UNets (Figure 53, A). The differences in the convolutions
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and connections in the Standard, Residual, and Dense 3D UNets are represented in
Figure 53, B. A representative diagram of the Hybrid-WNet architecture is shown
in Figure 54.

Figure 53: Top (A): Basic architectural framework. Bottom (B): Difference in
convolution blocks, surrounded by green to indicate the same region in (A). Standard:
previous feature maps are convolved and activated. Residual: previous feature maps
are directly added to convolutional output in a skip-connection before activation.
Dense: previous feature maps are continually concatenated together before
activation and convolution. BN: batch normalization.
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Standard 3D UNet
We first investigated the Standard 3D UNet, in which concatenations or
additions were used to combine equal-sized feature maps from the encoder to the
decoder side.
Standard architectural parameters:


1, 2, 3, or 4 layers



1, 2, or 3 initial convolution blocks



Increase in number of convolution blocks (convolution lambda) for each
layer of 0, 1, or 2



4 maximum convolution blocks



8, 16, and 32 initial filters



32, 64, or 128 maximum filters

Residual 3D UNet
The Standard 3D UNet was expanded to include residual connections for
each convolution block in a layer, with motivation from the ‘ResNet’ architecture 83 .
Residual connections have the benefit of allowing a “flow” of loss from previous
convolutions. This allows the model to create skip-connections over convolutions
that might not be necessary.
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Residual Network Architecture Parameters:


1, 2, 3, or 4 layers



1, 2, 3, or 4 initial convolution blocks



Increase in number of convolution blocks (convolution lambda) for each
layer of 0, 1, and 2



4 maximum convolution blocks



32 initial filters



128 maximum filters

Dense 3D UNet
A more complete “flow” of loss from previous convolutions can be realized
with the DenseNet architecture71 . This architectural style allows previous
convolutions to be re-used; optimizing the model’s reuse of feature maps enables
more diversified feature creation. The reuse of previous convolutions allows the
number of filters to be significantly reduced since the number of filters is increased
by a small amount each block (referred to here as the “growth rate”).
Dense Network Architectural Parameters:


2 or 3 layers



2 initial convolution blocks
133



Increase in convolution blocks (convolution lambda) for each layer of 0 or 1



4 maximum convolution blocks



8, 12, 16, and 32 initial filters



Filter growth rate of 0 and 4
Infinite maximum filters

Hybrid-WNet
Our Hybrid-WNet architectural style was inspired by that presented by Li et
al.99 to which we have made significant alterations. The architecture combines 2D
features extracted from the pre-trained 2D DenseNet71 with a 3D convolutional
neural network. Our model builds on the DenseNet 121 architecture implemented
in TensorFlow software120 . To turn this classifier into a semantic segmentation
algorithm, we created a UNet of the DenseNet 121 and performed bilinear
upsampling, followed by a convolution and the addition of encoding features. We
coined the term Hybrid-WNet on the basis of the hybrid approach of combining 2D
and 3D features, along with the W-shaped appearance of two UNets beside each
other, shown in Figure 54.
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Figure 54: Hybrid-WNet. (Left) Pre-trained 2D DenseNet 121 converted into UNet,
where final features were concatenated into 3D DenseNet. (Right) 3D DenseNet
architecture was defined as two layers, two convolution blocks in layer 0, three
convolution blocks in layer 1, and eight initial filters. BN: Batch Normalization
Our architecture and training varied from the original architecture in three
fundamental ways. First, in architecture training, we broke the training process
into four steps: 1) training only the new decoding side of the DenseNet 121, 2)
training the entire DenseNet121, 3) training only the 3D network with the
extracted 2D features, and 4) entire end-to-end training. By breaking up the
training process in this fashion, we ensured that we could use high learning rates
without the risk of “untraining” the pretrained layers or feature extractors. Second,
our 3D DenseNet contained truly dense layers, with extracted features shared
throughout the entirety of each layer; this enabled the use of significantly fewer
features.
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Modeling Training
All model training was performed using NVIDIA-Tesla V100 32GB GPUs172 .
All model creation, training, optimization, and evaluation was performed using
TensorFlow software version 2.2.0109 . The models were optimized using a sparse
categorical cross entropy loss and an Adam optimizer. Mixed precision was
enabled to reduce the training time.
The model was trained with two inputs, a CT image and a binary mask of
the liver. The liver mask automatically assigns a background to any voxel that is
not present within the liver, as any disease should be within the provided liver
contour. Training involved passing B*N*H*W*C tensors to the model, where the
(B)atch varied from 8 to 16, the (N)umber of slices was 32, the (H)eight was 120,
the (W)idth was 120, and the (C)hannels were 2 (i.e., the image and the binary
liver mask). Thus, a single pass might be 8x32x120x120x2 in size.
Hybrid-WNet
When training the 2D aspect of the Hybrid-WNet, 3D cubes were reshaped
into stacked 2D images. For example, a batch of 8x32x120x120x1 would be
transformed into 8*32x120x120x1. To ensure that the pre-trained weights were
taken advantage of, the first iteration froze all weights on the pre-trained encoding
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aspect of the architecture, only training the decoding aspect. Next, all weights were
made trainable, allowing the model to adjust any pre-trained layers.
Training the Combined 2D-3D WNet
After training the 2D part of the W-Net, we concatenated the 2D features
before classification onto the input of the 3D model. For the first iteration, all
weights from the 2D network were frozen, and only the 3D model was trained.
Next, all weights were unfrozen, allowing the model to be fine-tuned.
Hyper-Parameters
The learning rate is known to be one of the most important variables in
determining a model’s ability to converge; optimal rates vary based on the
architecture depth (layers), the number of convolution blocks, and the number of
filters in each block. For each model, a variation in the cyclical learning rate173 was
used (https://github.com/brianmanderson/Cyclical_Learning_Rate), where the
model started training at a minimum learning rate before linearly increasing to the
maximum and decreasing back to the minimum.
The minimum and maximum learning rates were defined using an in-house
written function
(https://github.com/brianmanderson/Finding_Optimization_Parameters). This
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function slowly increases the learning rate from a very low value (on the order of
1e-10) to a large value (of about 0.1) on the training dataset. The minimum and
maximum learning rates were extracted from the resulting training loss curve at
the points where the loss began to decrease and increase, respectively. Unique
minimum and maximum learning rates were found for each architectural
parameter for reach architectural style.
Model Optimization
To overcome the effect of random variable initialization, we ran each unique
model three times independently using randomly initialized variables for 101
epochs. Plotnine and Tensorflow’s Tensorboard
(https://github.com/tensorflow/tensorboard) with hyperparameter tuning were
used to identify any potential trends and to direct the model training. The final
model was selected on the basis of the Dice similarity coefficient (DSC) between
the validation set prediction and the ground truth during the training process.
Visual Evaluation
Disease sites can be small; therefore, quantitative metrics may lead to
inaccurate segmentation results. Prediction images were created on the validation
data during training to visually assess the training accuracy, shown in Figure 55.
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Figure 55: Examples of visualization of prediction on validation data during training.
Top row: Image being fed into the model, masked by the liver segmentation. Middle
row: Ground truth of disease contours. Bottom row: Prediction of disease contours,
set with a threshold of 0.5 to the binary mask.
This method has been implemented as a TensorFlow callback function
(https://github.com/brianmanderson/Callbacks).
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Modeling Evaluation
Seed and Threshold Values
The disease predictions from our model ranged from 0-1. Unfortunately,
because of slice thickness, the most inferior and superior aspects of a disease site
might have a lower probability than the “middle” of the disease. For this reason, we
used seed-point growth for the final prediction. Seed points were created to define
the likely starting point of a disease site, and then grown outwards to the threshold
value. The seed value and threshold values were selected on the basis of the
highest DSC in the validation dataset. The seed values ranged from 0.25-0.95 in
0.01 increments, and the thresholds ranged from 0.2 to 0.8 in 0.01 increments.
Quantitative Evaluation
The geometric performance of the model was evaluated on the test set using
the DSC and Median Surface Distance between the manual and predicted
segmentations. To evaluate our model, we report on predictions in a disease siteby-site, patient-by-patient, and “global” basis.
For the site-by-site comparison, each non-connected disease segmentation
of the test patients was considered to be an independent case. In that regard, we
computed the metrics between the manual segmentation and the closest
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continuous predicted disease segmentation, using the distance between site
centroids. For the patient-by-patient comparison, we computed the metrics
between the manual and predicted segmentations within the entire liver. For
global DSC, all images were stacked together. This metric comes from the LiTS
challenge170 . All metrics were computed using the resolution of the original
images.
The sensitivity of the model was evaluated on a site-by-site basis, where the
disease was considered to be identified if at least 45% of the manual disease
volume was overlapped by the predicted disease volume. The false-positive
volume was defined as the volume of the predicted disease segmentation outside
of the ground truth disease segmentation and consisted of two errors: oversegmentation of the actual disease volume and erroneous segmentation of the
normal liver area as disease. The erroneous false-positive volume was quantified
as the volume that was completely unconnected to any ground truth disease
segmentations and the over-segmentation false volume as the total predicted
volume minus the erroneous volume, shown in Figure 56.
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Figure 56: (Left) Overlay between predicted (white) and ground truth (red) disease
segmentations. (Right) Subtraction of the predicted and ground truth disease
segmentation and over-segmentation of the disease volume (blue) and unconnected
erroneous false-positive region (green). The sum of blue and green is the falsepositive volume.
Qualitative Evaluation
To enrich the quantitative evaluation, we also evaluated quantitative
metrics. For large structures, a high DSC can hide clinically important inaccuracies,
while for smaller structures, a low DSC can be overly critical 174 . Therefore, a
qualitative assessment of both CRLM and ablation segmentations was performed
by a radiology-trained physician fellow (1, EYL) and two board-certified
radiologists: an interventional radiologist, (2, BCO), and a diagnostic radiologist,
(3, HCK), both of whom have more than 10 years of experience.
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We retrospectively identified 18 patients who had previously undergone
thermal ablation therapy at our institution under an Institutional Review Boardapproved study; these patients had 24 CRLM sites and 19 ablation sites. The
predicted CRLM and ablation contours were scored independently by both
radiologists and the radiology physician fellow based on a Likert quality scale of 15. The criteria for the scale are shown in Table 9.
Table 9: Likert Scoring for Assessment of Colorectal Liver Metastasis (CRLM) and
Ablation Contours
Score

Criteria

5

Excellent

Negligible changes, could be used clinically without editing

4

Good

Minor changes on fewer than 4 slices or changes that would take less than 10
seconds to fix

3

Fair

Editing needed on multiple slices, but fewer than half

2

Poor

Editing needed on more than half of the slices

1

Very poor

Contours are poorly predicted, missed disease

5.1.3 Results
The best validation loss scores for each architectural style were for the
Standard UNet: 0.041, Residual UNet: 0.024, DenseUNet: 0.016, DenseNet2D
(Encoder frozen): 0.022, DenseNet2D (All trainable): 0.013, DenseNet3D (2D
frozen): 0.011, and DenseNet3D (All trainable): 0.0092.
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Quantitative
The best model was the Hybrid-WNet model: the 3D UNet contained two
layers, two convolution blocks, and 32 filters and had a convolution lambda of two.
The model consisted of 14,497,600 parameters (14,408,960 that were trainable
and 88,640 that were non-trainable).
A seed value of 0.67 and threshold value of 0.30 resulted in the highest
overall DSC in the validation dataset. LiTS test set (n = 70) predictions required a
mean of 9.58 seconds, with a standard deviation of 2.32 seconds.
Site-by-Site Evaluation
Site-by-site evaluation for 3D-IRCADb and institutional data are
summarized in Table 10.
Table 10: Mean, Minimum, and Maximum Dice Similarity Coefficients and Median
Surface Distances and Sensitivities for Individual Disease Sites by Differing Size
Criteria of the 3D-IRCADb Dataset
Dice Similarity
Coefficient
Mean Min
Max

Disease Site
Diameter

Sites

Median Surface Distance (mm)

< 15 mm

73

0.16

0.00

0.89

28.25

0.67 108

≥ 15 mm

48

0.74

0.00

0.94

1.23

0.28 19.4

Median

Min

Max

Sensitivity
23%
(15 of 73)
98%
(47 of 48)
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3D-IRCADb Data
On a site-by-site basis, the median (min-max) median surface distance for
sites less than 15 mm in diameter (n=73) was 28.25 mm (0.67-108) and for sites
greater than 15mm in diameter (n=48) was 1.23 mm (0.28–19.4). The mean (minmax) DSC for sites less than 15 mm in diameter (n=73) was 0.16 (0.00 - 0.89) and
for sites > 15 mm in diameter (n=48) it was 0.74(0.00 - 0.94) (Table 10).
Institutional Data
For the pre-treatment CECT in which previously defined manual contours
were present in the CRLM (n=19 sites), the mean (min-max) DSC was 0.80 (0.590.91), with 84% (16/19) having a DSC of 0.76 or greater. For the post-treatment
CECT where previously defined manual contours were present of the ablation zone
(n=14 sites), the mean (min-max) DSC was 0.75 (0.09-0.90), with 71% (10/14)
having a DSC of 0.76 or greater.
We compared our model results to those of other authors, as summarizd in
Table 11; our size distributions were varied to match theirs and thus to ensure a
fair comparison.
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Table 11: Comparison of CRLM Segmentation Results from Our Model and the
Literature. Green Box Indicates More Disease Sites (n), Better Dice Similarity
Coefficient (DSC), or Higher Sensitivity from Our Model.
Method

Model

Presented method

Hybrid-WNet

Vorontsov et al 169

FCN

Li et al 99
Seo et al 98

Hybrid Dense UNet
mUNet

Disease Diameter and Source
< 10 mm
10-20 mm
15-20 mm
≥ 20 mm
LiTS
3D-IRCADb
< 10 mm
10-20 mm
> 20 mm
LiTS
3D-IRCADb

No. of Sites
42
49
18
30
70 patients
15 patients
30
n = 35
40
72 patients
5 patients

Mean DSC
0.00
0.43
0.68
0.77
0.810 global
0.69
0.14
0.53
0.68
0.824 global
0.68

Sensitivity
7%
59%
94%
98%
10%
71%
85%
-

Patient-by-Patient Evaluation
Patient-by-patient evaluations for 3D-IRCADb and institutional data are
summarized in Table 12.
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Table 12: Metrics of Dice Similarity Coefficient, Median Surface Distance (mm), FalsePositive Discoveries (Per Patient), and False-Positive Volume (cc) for 15 3D-IRCADb
Test Patients
Metric
Dice similarity coefficient
Global Dice similarity coefficient
Median surface distance (mm)
False-positive discoveries (per
patient)
False-positive volume (cc)
Erroneous false-positive volume
(cc)
Over-segmentation false-positive
volume (cc)
Metric
Dice similarity coefficient
Median surface distance (mm)
False-positive discoveries (per
patient)
False-positive volume (cc)
Erroneous false-positive volume
(cc)
Over-segmentation false-positive
volume (cc)
Metric
Dice similarity coefficient
Median surface distance (mm)
False-positive discoveries (per
patient)
False-positive volume (cc)
Erroneous false-positive volume
(cc)
Over-segmentation false-positive
volume (cc)

Overall Patients (N = 15)
Standard
Median Min
Max
deviation
0.74
0.40
0.89
0.16
0.81
N/A
N/A
N/A
1.95
0.57
8.00
1.90
1

0

7

2.0

4.25

0.08

28.34

7.48

2.35

0.00

14.56

5.01

1.24

0.00

17.56

5.50

CRLM Patients (N = 15)
Standard
Median Min
Max
deviation
0.78
0.28
0.91
0.17
0.78
0.01 83.28
27
1

0

4

1.2

2.43

0.28

14.47

4.68

1.05

0.00

14.23

4.54

0.73

0.23

3.68

0.97

Ablation Patients (N = 9)
Standard
Median Min
Max
deviation
0.79
0.42
0.89
0.16
0.76
0.01
5.72
1.76
2

0

6

1.6

27.8

5.84

174.07

61.25

5.62

0.00

107.47

32.77

11.40

4.35

172.54

50.97
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3D-IRCADb Data
On a patient-by-patient basis, the median (min-max) median surface
distance was 1.75 mm (0.57–7.63 mm), the DSC was 0.73 (0.41-0.88), the number
of false-positives was 1 (0-4), the false-positive volume was 4.25 cc (0.08-28.34
cc), the erroneous false-positive volume was 2.35 cc (0.00, 14.56 cc), and the oversegmentation false-positive volume was 1.24 cc (0.00, 17.56 cc) as shown in Table
12. Note that a single patient might have multiple disease sites of varying sizes. The
global DSC score was 0.81.
Institutional Data
Manual contours of the CRLM and ablation zones were not always present;
for this reason, fewer sites were used than in the qualitative analysis.
For the pre-treatment CECT in which previously defined manual contours
were present in the CRLM (n=15 patients), the mean (min-max) DSC was 0.67
(0.28-0.91), with 84% (16/19) having a DSC of 0.76 or greater. For the posttreatment CECT, in which previously defined manual contours were present of the
ablation zone (n=9 patients), the mean (min-max) DSC was 0.72 (0.42-0.89), with
67% (6/9) having a DSC of 0.75 or greater.
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Qualitative Evaluation
The mean (min-max) Likert scores for all qualitative patient gross tumor
volumes (n=24) were interventional radiologist: 4.7 (4-5), diagnostic radiologist:
4.6 (4-5), physician fellow 4.9 (4-5), and majority: 4.8 (4-5). The mean (min - max)
Likert scores for each qualitative patient ablation volume (n=19) and the majority
score were interventional radiologist: 4.1 (2-5), diagnostic radiologist: 3.8 (2-5),
physician fellow 4.5 (3-5), and majority: 4.1 (2-5). All (24/24) of the CRLM
contours and 84% (16/19) of the ablation contours had a majority Likert score 4
or 5, shown in Table 13.

Table 13: Breakdown of Likert Score (1-5) for Predicted Contours of CLM and
Ablation Sites by Each Reviewer

Mean
Min
Max
%≥4

Reviewer 1
4.9
4
5
100

Mean
Min
Max
%≥4

Reviewer 1
4.5
3
5
95

CRLM Scoring (n = 24)
Reviewer 2
Reviewer 3
4.7
4.6
4
4
5
5
100
100
Ablation Scoring (n = 19)
Reviewer 2
Reviewer 3
4.1
3.8
2
2
5
5
89
74

Majority Vote
4.8
4
5
100
Majority Vote
4.1
2
5
84
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A breakdown of the individual scores for each site by each reviewer can be
seen in Figure 57.

Figure 57: (Top) Likert score by each reviewer for each disease site. (Bottom) Likert
score by each reviewer for each ablation site. A higher value is associated with higher
quality.
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5.1.4 Discussion
In this study, we described a Hybrid-WNet model architecture for the
segmentation of the disease sites and ablation areas in the context of CRLM treated
with ablation therapy. The model was further evaluated using the Likert scoring
method by two board certified radiologists (BCO, interventional radiologist and
HCK, diagnostic radiologist) and a radiology trained physician fellow (EYL), with
majority voting scores 4 or 5 out of 5 for 100% (24/24) of the disease and 84%
(16/19) of the ablation segmentations. Our work is highly innovative in regard to
the proposed model architecture and training workflow (as is discussed below).
The prediction process has been implemented in a treatment planning system
(RayStation 9B, RaySearch Laboratories, Sweden) 116 and can perform
segmentations within 30 seconds, making it highly suitable for clinical use.
Our work is highly innovative because of the Hybrid-WNet model
architecture and the training of the model; the model had a 98% (47/48)
sensitivity on disease sites larger than 15 mm in diameter, with predictions in
within 30 seconds. Our model performed similarly to the state-of-the-art
architectures shown in Table 11 with respect to DSC and sensitivity.
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The proposed Hybrid-WNet architecture in this study differs from the
model that inspired it99 by impvoring the 2D feature extractor, and connecting all
of the convolutional layers within the convolution blocks between the encoding
and decoding of the 3D DenseNet. Previously published studies proposed similar
architectures that were focused only on dense connections within a single
convolutional block101,175,176 . Our proposed implementation allows the model to
receive inputs from every convolution of the same image size across the entire
network. This global passing of convolution layers across the network removes
bottlenecks in each convolution block, which is something that is particularly
important with dense connections where convolutions can be re-used.
Segmentation of CRLM has historically been difficult because of the
relatively small size of the lesions and the large search area. The extent of disease
can vary from patient to patient, ranging from a single lesion to multiple lesions.
Simple class weighting of disease would lead to favoring training in patients with
more disease sites. Our method of splitting the liver into cubes that are centered
specifically on disease sites ensures that the model learns using a more balanced
representation of the data. The training workflow was designed to allow the model
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to learn from batches that contains cubic images from multiple patients at once,
thereby enabling the creation of a more generalized model.
While fully convolutional networks have been previously investigated for
the segmentation of CRLM169 , only a quantitative assessment of model
performance has been reported. The mean DSC and sensitivity of our model were
slightly lower than those presented by Vorontsov et al 169 , who had more test sites
for two of the criteria (n=42 vs n=30 for lesions smaller than 10 mm, and n=49 vs
n=35 for those from 10-20 mm). Similar findings have also been reported by Christ
et al;159 however, their work focused on primary liver disease. Within our
institutional data, 84% (16/19) of the disease sites had a DSC exceeding 0.76,
which is reported as the inter-observer variability for CRLM segmentation177 .
5.1.5 Limitations
Our study has several limitations. The mean sensitivity was only 7% in
disease sites that were smaller than 10 mm in diameter compared with 98% in
sites that were larger than 15 mm in diameter. We believe that the low sensitivity
in small sites may be partly due to the test data used, where several 10-15 mm
disease sites were present on a single scan slice. Unfortunately, manual contours
were not present for all of the institutional CRLM and ablation data, which limited
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our quantitative comparison to 19 of the 24 CLRM sites and to 9 of the 19 ablation
sites.
Majority voting showed poor Likert score (lower than 4) for three ablation
sites. The predictions for these sites can be seen in Figure 58, where disagreement
about the boundary of the ablation zone and the time needed for correction
resulted in a range of scores from the reviewers.
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Figure 58: Three cases where majority voting had a Likert Score less than 4. (Top)
We believe that the model failed due to similarity in appearance to the gallbladder.
(Middle, Bottom) Model over-segmented regions around the ablation zones.
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The measurement of the false-positive volume seemed to be highly biased
when there were small amounts of over-segmentation on large tumors; this was
the rationale for the creation of the erroneous and over-segmentation falsepositive volumes. To ensure transparency, we included all three and relied on
qualitative assessment to add weight to the quality of the contours.

5.1.6 Conclusions
The proposed Hybrid-WNet model provided fast and accurate CRLM and
ablation zone segmentations for CECT. Our model’s results were well accepted by
the reviewers, with all three scoring the disease segmentation (n=24) as 4 or 5 on
the Likert scale, and 84% (16/19) as 4 or 5 with ablation segmentation. We believe
that this model can provide clinical benefits in the detection of CRLM, the
assessment of ablation therapy, and automated planning for radiation therapy.
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5.2 Segmentation of the liver segments
5.2.1 Introduction
There are over 700,000 deaths worldwide that are attributed to liver tumor
involvement1 . This liver tumor involvement is characterized as either primary liver
disease or secondary liver disease. In primary liver disease, hepatocellular
carcinoma (HCC) represents 80% of the liver cases, followed by
cholangiocarcinoma (C-HCC) which represent 15%5 . Unfortunately, due to factors
such as non-alcoholic fatty liver disease and alcoholic liver disease, the incidence of
HCC is on the rise in the modern world4 .
While surgical resection has the highest five-year overall survival rate in both
primary and secondary liver disease7 , it is only an option for about 30% of
patients9–11 . The estimated remnant liver volume post-resection is a determining
factor in identifying surgical candidates, and is typically required to be at least
25% to prevent post-hepatectomy liver failure178–181 . Remnant liver volume is an
estimated calculation based on segmentations of the eight liver lobes, or left and
right lobes, which are the parts of the liver. Unfortunately, accurate liver lobe
segmentation in CT scans can be a challenging process, with relatively subjective
interpretations of exact lobe extent.
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While commercial semi-automatic software exists (such as GE Hepatic V-Car) to
assist the user in identifying the liver lobe volume, the process is far from
automatic, which invites operator variation in the output assessment.
We have developed a fully automatic deep learning segmentation system to
identify segments common in a left (1, 2, 3, and 4) and right (5-8) hepatectomy.
Fully convolutional networks, and in particular the UNet style architecture, have
been highly successful in segmentations of multiple organ sites73,159,174,182–185.
We propose that a fully-convolutional network, built with atrous convolutions, will
be able to robustly segment segments 1, 2, 3, 4, and 5-8 within inter-observer
variability and lead to more robust evaluations of potential surgical candidates.
5.2.2 Methods
Quantitative Data
For this retrospective work, 69 patients who had undergone liver resection
surgery at our institution were collected under an IRB approved protocol, and 10
image sets were obtained from the Medical Image Computing & Computer Assisted
Intervention (MICCAI) multi-atlas challenge (data:
https://www.synapse.org/#!Synapse:syn3193805/wiki/89480). Segmentations of
the individual liver lobes were defined with the assistance of a commercially
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available semi-automatic system. Segments were created by a senior medical
imaging technologist with five years of experience, a graduate student trained in
liver lobe segmentation, a post-doctoral fellow, and a research assistant.
The institutional patients were randomly separated into a training and
validation sets of 70 and 9, respectively, shown in Table 14.
Table 14: Distribution of data for training, validation, and completely withheld test.
Source Information

Image Distribution

Source

Patients

Training

Validation

MDACC

69

60

9

MICCAI

10

10

-

Identifying inter-observer variability
To measure the present inter-observer variability in the segmentation of
the liver segments, we analyzed the data from five patients. Six clinically trained
technologists independently segmented segments 1, 2, 3, 4, and 5-8. Note that not
all technologists segmented all of the patients. The number of technologists who
segmented segments 1-4 on each patient were: 6, 5, 5, 4, and 3, while segments 5-8
were segmented by at most two technologists. The difference in volume for each
segment across the technologists in a single patient is shown in Figure 59.
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Figure 59: Spread of volumes measured by segmentations of each technologist (n=6)
for a particular patient.
The percentage difference in volume across each patient and their average
is given in Table 15.
Table 15: Percentage volume variability in the segmentation of each liver segment by
the technologists. Note that segments 5-8 had at most two technologists segmenting
them, and as such has a relatively small percentage variability.
Patient

% Variability
Segment 1

Segment 2

Segment 3

Segment 4

Segments 5-8

0

11.2

20.5

23.2

7.7

3.5

1

5.2

3.2

2.1

2.4

-

2

11.0

29.9

31.4

7.4

7.9

3

16.9

39.3

27.3

3.8

0.2

4

5.9

7.7

6.0

3.5

-

Average

10.0

20.1

18.0

5.0

3.9

The distribution of Dice similarity coefficients (DSC) among each of the
technologists across each patient can be seen in Figure 60.
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Figure 60: Distribution of mean Dice similarity coefficients for each segment from
each patient. Note that the relatively small spread of segments 5-8 is likely due to
only having two technologists who segmented those regions.
Note that due to the varying volumes of each segment, the Dice similarity
coefficient (DSC) will be harsher on small segments (e.g., segment 1) and less
critical of larger segments (namely the combination of 5-8). To help identify the
spatial variability in segmentation, we created a method of identifying the distance
from the consensus contour to the boundary of each contour. To demonstrate,
three such segmentations of segment 1 are shown in Figure 61.
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Figure 61: Segmentation of segment 1 by three different technologists.
To reduce the impact of a single user’s performing a poor segmentation, we
identify an ‘agreement’ contour as having been segmented by the majority of users.
With this ‘agreement contour’ we gradually dilate the volume by 1 mm in each
direction, calculating the increase % of overall points included by the dilated
contour. In this fashion we can identify a 95% confidence interval for each patient
and each segment.
The % agreed upon vs expansion for each direction (x, y, and z) for
segments 1-4 are shown in Figure 62, Figure 63, and Figure 64, respectively.
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Figure 62: The percentage agreed vs expansion of the ‘agreement’ contour for each
segment in the X direction.
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Figure 63: The percentage agreed vs expansion of the ‘agreement’ contour for each
segment in the Y direction.
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Figure 64: The percentage agreed vs expansion of the ‘agreement’ contour for each
segment in the Z direction.
In this way, we now have a ‘ground truth’ starting contour based on agreement, as
well as a sigma to define our confidence in each direction. The distance expansions
that were needed to cover 95% of the segmented points are listed in Table 16.
Table 16: Expansion of the ‘agreement contour’ that was required in mm to cover
95% of the voxels segmented by the technologists.
Direction

95% Coverage Expansion (mm)
Segment 1

Segment 2

Segment 3

Segment 4

x

24

22

26

27

y

17

18

19

26

z

3

4

4

6

Ground Truth Pre-Processing
The manually delineated liver segments often suffered from having small
areas of overlap in the initial segmentations or from containing regions that were
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defined as liver, but did not have a label assigned to them. In order to remedy this
issue, we removed any labels of overlap, and then used the 3D distance map to
assign the voxel to the nearest label, shown in Figure 65.

Figure 65: Left: Initial segmentation of liver segments, where overlap has been
assigned to background.
Right: Corrected segmentation where each voxel within the liver is assigned to the
nearest label.
Note that for some cases, the technologists segmented segments 5-8
individually, but for training the model, these lobes were combined into a single
label. All training and validation images and masks were resampled to have a slicethickness of 5 mm via bi-linear interpolation and nearest-neighbor resampling,
respectively. Predictions on the test set were resampled to the original resolution.
Model Architecture
For this work we looked specifically at 3D UNet style architectures. We
investigated using two convolutions between each pooling layer with 3x3x3
kernels as well as replacing the two convolution blocks with two atrous blocks
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with a dilation rate of 3. The benefit of atrous blocks is that they allow the model to
have an increased receptive field without significantly increased computational
requirements.
For example, two 3x3x3 convolutions will have an equivalent receptive field
size of 5x5x5, while an atrous convolution, which is a 3x3x3 convolution followed
by a 3x3x3 convolution with a dilation rate of 3 (essentially a 7x7x7 convolution
with padded 0’s) will have a receptive field size of 9x9x9. This is explained in a 1D
example in Figure 66.

Figure 66: Representation of receptive field size for two 1x3 convolutions vs atrous
convolution.
Left: two ‘standard’ 1x3 convolutions is equivalent to a 1x5 convolution, but the
representation of voxels is not evenly distributed.
Right: 1x3 convolution followed by 1x3 convolution with stride of 3 is equivalent to a
1x9 convolution, and the representation of voxels is evenly distributed.
We investigated varying layers in depth from 1 to 6, the number of
convolution layers from 0 to 3, the initial number of filters from 8, 16, or 32, and
the maximum number of filters to be 32 or 64.
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Training
Training Preprocessing
Leveraging previous work to create a liver autosegmentation network, a
segmentation of the entire liver was provided for all scans. Due to variations in
Hounsfield Units (HUs) within the liver based on contrast enhancement, we
created a patient-specific normalization scheme. Each scan is normalized by first
binning the HUs of the liver into 1000 bins. The full-width half-max of the peak is
then used to define the mean and standard deviation for image normalization.
Data Presentation
Data was prepared by creating a bounding box around the liver contour.
This reduced the computation load for training a model, and it leveraged the
knowledge that segments of the liver should not occur outside of the liver. Each
data sample was padded with 0’s to ensure proper concatenation of features
across the UNet after max-pooling.
Model Training
All models were trained with the Adam optimizer, Categorical Cross
Entropy loss function, and cyclical learning rate. The cyclical learning rate
functions by linearly cycling between a minimum and a maximum learning rate,
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with a decrease in the maximum and minimum learning rates equal to 0.5 after 8
epochs. A unique minimum and maximum learning rate were determined for each
architecture by gradually increasing the learning rate across the training data. The
moment where the loss begins to first decrease will be the minimum learning rate,
while the moment where loss begins to increase again will be the maximum
learning rate, shown in Figure 67.

Figure 67: Example of learning rate finder. The learning rate is gradually increased
from a very small number to a larger number. The point when loss begins to decrease
is the minimum learning rate, and when it begins to increase is the maximum
learning rate.
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Class imbalance
There is a naturally occurring class imbalance within the segments of the
liver. Segment 1 is normally significantly smaller than the other segments. This
imbalance in size can lead to a decrease in importance to the model during
training. To mitigate this issue, we measured the mean volume of each segment
across the entire patient set and increased the class-weight for each segment based
on its volume relative to the entire liver in a weighted categorical cross entropy
function.
Visualization
Model training was evaluated using an in-house written TensorFlow
Callback https://github.com/brianmanderson/Callbacks, TF2_Callbacks. This
enabled the visualization of the prediction of the liver segments during the training
process, ensuring that reported the metrics were associated with a proper
segmentation of the individual lobes, at least qualitatively.
Seed point growing
We investigated a method of seed point growing for the final prediction
decision. Previous work has shown that a simple majority threshold does not
always lead to the highest DSC score74 . We investigated the combinations of
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starting seed points and final threshold values for each segment, with seed values
ranging from 0.5 to 0.95 in 0.05 increments, and thresholds ranging from 0.1 to 0.9
in 0.1 increments.
Cleaning Predictions
We leveraged the fact that liver segments are fully connected threedimensionally to help improve the final predictions. After seed point growth, only
the largest fully connected structure from each segment was maintained. Any
overlap of segments, as would be caused by thresholds less than 0.5, was removed.
The final segments were then grown three-dimensionally to fill the remaining liver
contour, similarly to what is shown in Figure 65.
Evaluation
The accuracy of the auto-generated contours was evaluated in two ways.
First, against the completely withheld test set of nine patients, we evaluated the
prediction DSC on each lobe, and the mean surface distance (MSD) between the
generated contour and the ground truth contour.
𝐷𝑆𝐶 = 2

𝐴∩𝐵
𝐴+𝐵

(1)
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When evaluating the model, comparisons were made only at the original
image resolution. This means that the predictions were resampled back to the
original image resolution before evaluation via DSC or MSD.
5.2.3 Results
Our final selected model, which was based on the combined DSC, was three
layers deep, with two convolution blocks, twelve filters, a minimum learning rate
of 2e-5 and a maximum learning rate of 1e-2.
Segment seed point growing
We investigated a combination of seed and threshold values for each
segment. The highest overall DSC was found with seed values of 0.9 for all
segments, and threshold values of 0.5, 0.75, 0.25, 0.25, and 0.75 for segments 1, 2,
3, 4, and 5-8, respectively. This means that the criteria to be listed as ‘segment 4’
would grow from all voxels with equal to 0.9 to voxels with values as low as 0.25.
Quantitative
The absolute volumetric difference between each segment and the ground
truth is shown in Table 17. The median (standard deviation) absolute volume
differences were for Segment 1: 25% (17%), Segment 2: 50% (29%), Segment 3:
29% (15%), Segment 4: 13% (16%), and Segments 5-8: 7% (4%).
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Table 17: Percentage absolute volume difference between predicted lobe segments
and ground truth for each patient.
Patient

% Absolute Volume Difference
Segment 1

Segment 2

Segment 3

Segment 4

Segments 5-8

1

3

22

3

16

7

2

12

20

32

0

1

3

25

31

35

8

6

4

33

94

45

2

15

5

1

62

48

8

9

6

49

37

38

28

7

7

31

81

23

50

12

8

21

17

7

3

2

9

52

84

33

0

7

Mean

25

50

29

13

7

Std

17

29

15

16

4

Qualitative
Qualitative visualization of the training process ensured proper
optimization and predictions were occurring relation of the combined DSC and
actual segmentation ability. A visualization of the nine validation patients at the
last epoch, Figure 68.
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Figure 68: Visualization of the prediction process during training on the nine
validation cases. Top: masked liver image. Middle: ground truth segmentation.
Bottom: Prediction segmentation.
5.2.4 Discussion
Most previous work has focused on the identification of the liver vessels186
or the estimation of volumetry for surgery post-resection187 . Our method does not
intrinsically attempt to segment the vessels, and thus it is difficult to compare to
others in this regard. For the estimation of volumetry for resection, we can see a
large difference in the absolute segmentation volume for segments 1-3, but it is
also important to realize that these segments are the smallest by volume. Segments
5-8, by comparison, have a mean absolute volume difference of only 7%. Previous
work by Yang et al.187 reported a percentage absolute error of 6.8% +/- 3.2% of
resected liver volume. We would argue that for a left or right hepatectomy our
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model provides useful information regarding the volume of the liver which would
be removed.
Limitations
Our largest limitation is that we do not have a completely withheld test set
for comparison. It would be very useful to have this extra dataset both as a
quantitative comparison outside of our previous optimization, and as a qualitative
comparison between previously defined manual contours and our automated
contours.
5.2.5 Conclusions
Despite the limitation, our work was able to contours segments 5-8 with a
low average percentage absolute volume difference. These models show their
potential for useful segmentation of the liver segments for potential surgical
resection. Further work with an expanded dataset for training and a completely
withheld test set for quantitative and qualitative evaluation is warranted.
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Chapter 6: Deep learning outcome predictions model
6.1 Introduction
Colorectal cancer is the third most commonly diagnosed cancer in the
United States17 , with 60-70% of patients develop colorectal liver metastasis
(CRLM) over the course of their disease16,18,19 . While surgery is the gold standard
for curative intent, with an overall 5-year survival rate ranging from 40% to
60%188–191 , it is only available to approximately 20% of patients at the time of
diagnosis30 .
Percutaneous ablation therapy (PTA), via microwave or radiofrequency
ablation, has been shown to have similar overall 5-year survival rates, from 24% to
51%130,131,192 , to surgery. Overall survival might be limited, though, by, one of the
largest challenges with PTA, namely ensuring sufficient ablation delivery.
Current work on assessing ablation efficacy has focused on 2D margin
assessment141 , 3D margin assessment with rigid registration142 , or 3D margin
assessment with some form of deformable registration193 . Each of these methods
relies on the single metric of minimum delivered margin, without considering the
context of the surrounding tissue.
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Deep learning classification methods have successfully extracted and
interpreted image information beyond what is easily identified by humans. Current
deep learning work has produced outcome predictors from medical images in a
number of tasks, from the detection of pneumonia194 , to histopathological
classification84 , and the identification of radiosensitive populations195.
We hypothesize that a deep learning classification model, with
convolutional layers for feature extraction and dense layers for feature
interpretation, could provide a useful prediction outcome model of ablation
efficacy for the interventional radiologist who is performing such treatments.

6.2 Materials and Methods
Data
Selection
We retrospectively accumulated 119 patients who had undergone
percutaneous ablation therapy (PTA) for metastatic colorectal liver metastasis
(CRLM) at our institution. The patient selection criteria included: a minimum
follow-up period of six months and a maximum of two months between pretreatment and post-treatment contrast enhanced CT imaging. The follow-up data
included three possible outcomes: residual disease, local progression, and no
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progression. For this work, residual disease and local progression were combined
into a single outcome of progression.
Segmentation
CRLMs were manually segmented on pre-treatment contrast-enhanced CT
scans and validated by a radiology-trained physician fellow. CRLM segmentations
were labeled based on the outcome status of the individual site as progression or
non-progression, resulting in a total of 197 sites. An example of a patient with four
sites, three of which did not locally progress, shown in Figure 69.

Figure 69: Example of patient with four disease sites. Three of the treated sites did
not develop progression (green), and one site did progress (red).
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Liver contours for the pre-treatment and post-treatment scans were
generated automatically with our in-house liver auto-contouring algorithm174 ,
manually inspected, and edited as needed.
Image Registration
Automatic, intensity-based, rigid image registration including rotation was
performed centered on the liver within the Raystation Treatment Planning
system116 . Following rigid-registration, biomechanical model-based deformable
image registration (Morfeus) was applied within the treatment planning system
(RayStation v9B, RaySearch Laboratories, Stockholm, Sweden), using the liver
contours as boundary conditions. Morfeus has been extensively validated in the
liver 52,58,60,146,150,196 .
Data Extraction
The pre-treatment CT, the rigidly registered post-treatment CT, and the
deformable resampled post-treatment CT, along with the corresponding liver and
tumor segmentations were converted into nifti files using our in-house written
DicomRTTool197 . Using SimpleITK113 , all images and masks were resampled to
dimensions of 5x1x1 mm, using bilinear interpolation and nearest-neighbor
resampling, respectively.
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Presentation to model
Image ‘slabs’ of size 32x64x64 were extracted for each treated site, centered
on the segmented disease. Several examples of the pre-treatment image (on the
left) and the post-ablation (on the right) are shown in Figure 70.

Figure 70: Examples of ‘slabs’ from a variety of patients. Image on the left is pretreatment and image on the right is post-ablation. Note that the nomenclature is
patient ID_site#, so 42_0 and 42_1 are both from the same patient.
Distributing the data
Data was selected based on patient ID, not individual site. This ensured
that no patient was in both the training and the validation sets, even if
treated in multiple sites. One-third of the patients with any progression sites
were randomly selected to be part of the validation set. We then randomly selected
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one-third of the patients who only had non-progression sites also to be in the
validation set. The final distribution of data can be seen in Table 18.
Table 18: Distribution of patients and lesions between training and validation sets.
Note that patients were split up based on patient ID, so a single patient would never
be in both the training and the validation groups.

Source Information

Status

Image Distribution

Non-Progression
Source

Patients

Lesions

Train

Validation

132

94

38

65

43

22

Progression
MD Anderson
Cancer Center

119

197

Architectures
We investigated several alterations to adapt convolutional neural networks
for feature extraction into densely connected networks for outcome. The
framework of the feature extraction has three parts: First, convolution blocks are
performed in a manner similar to the DenseNet71 architecture, where previous
feature maps are concatenated immediately onto deeper layers, enabling efficient
backpropagation and reuse of filters. Second, a transition block is optimized to
reduce the number of filters to a fraction ranging from 0.5 to 1, where 1 indicates
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no reduction and 3D max pooling with a stride of 2. Third, feature extraction ends
with a global max pooling layer.
The framework of the densely connected network has two parts: First, a set
number of dense connections followed by a dropout layer. Second, the model
predicts two classes, progression and no-progression, by using a soft-max
activation.
We investigated several parameters of both the feature extractor and the
densely connected prediction, as well as parameters that are outside of the
architecture. Each architectural style was run three times to ensure that poor
initialization was not by happenstance the root cause of poor performance.
Feature extraction parameters:


4, 8, 16, or 32 filters as the number of filters to start the feature extraction



4, 8, 16, or 32 as the rate of increase in the number of filters (growth rate)



1, 2, 3, 4, or 5 convolution blocks in each dense layer



1, 2, 3, or 5 dense convolution blocks followed by transition layers



0.5, 0.75, or 1.0 the fraction of filters to decrease by each transition
Densely connected parameters:



0, 1, 2, 3, 4, 5, or 7 number of densely connected layers



64, 128, 256, or 512 number of connections in each layer



0.5 or 0.0 dropout for fraction of connections to drop
Other hyper-parameters:
182



Min and max learning rate were created on a model-by-model basis



Adam or Stochastic gradient descent optimizers



Categorical cross entropy, or Cosine loss

Training the model
We investigated presenting the data in eight different ways, involving
combinations of the pre-treatment image, the rigidly registered post-treatment
image, the deformably registered post-treatment image, segmentations of the liver,
and disease. A breakdown the combinations is shown in Table 19.
Table 19: The methods of presenting data to the model. Note that across all 8, the
pre-treatment contrast enhanced CT is presented. Next, either the deformed or rigidly
registered post-treatment image is presented. Segmentations of the liver and or
disease are also included.
Imaging
Pre-Treatment

Post-Treatment Deformed

x

x

x

x

x

x

x

x

Contours
Post-Treatment Rigid

Liver

Disease

x
x
x

x

x

x

x

x

x

x

x

x

x
x
x

x
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To balance the presentation of progression and no-progression, we created
two TensorFlow data-generators with interleaving outputs. With a batch size of 32,
this ensured that each training step had 16 sites with progression and 16 sites
without progression. Each generator would reshuffle and repeat, meaning that the
progression data were sampled more often than the no-progression data. This
decision was influenced by a recommendation by Tensorflow when working with
imbalanced data,
https://www.tensorflow.org/tutorials/structured_data/imbalanced_data.
Cosine Loss
Due to the limited and biased nature of our dataset (69% of data was noprogression, 31% was progression), we quickly noticed a problem of model
overfitting in the loss and AUC curves. Normalization was introduced to the model
in the form of L2 normalization and dropout in the dense connections. Dropout
introduces sparsity into the dense connections, helping to alleviate overfitting, and
L2 normalization attempts push the weights of the connections to be small but not
0. Unfortunately, these approaches did not seem to alleviate the overfitting.
Recent work has shown that a large part of the overfitting that arises from
having biased datasets can be related to the usage of a softmax + crossentropy loss
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function198 , and those authors propose the use of a cosine loss function. The cosine
loss focuses on increasing the similarity between the L 2 -norm of the prediction and
the ground truth, ‘bounding’ the loss to fall within a unit sphere, Equation (2). Note
that we added 1 so that it would always be positive, ranging from 0-2, rather than
the original range of the cosine function from -1 to 1. In contrast, the cross entropy
and softmax contains exponential and log functions, so that arbitrarily high values
can appear.

Figure 71: Heat maps of two loss functions in a 2-D feature space. Note that the
cosine loss is bounded within a range from 0 to 2, while softmax + cross-entropy can
take on arbitrarily large values. Figure copied from 198 .

𝐶𝑜𝑠𝑖𝑛𝑒 𝐿𝑜𝑠𝑠 = 1 − 𝜎𝑐𝑜𝑠 (𝑥, 𝑦) = 1 −

⟨𝑥, 𝑦⟩
⟦𝑥⟧2 ∙ ⟦𝑦⟧2

Equation
(2)
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After adopting the cosine loss function the model loss curves appeared to
have less overfitting and consequently the cosine loss was adopted for the rest of
the work.
Learning Rates
Unique minimum and maximum learning rates were identified using our inhouse learning rate finder,
https://github.com/brianmanderson/Finding_Optimization_Parameters, adapted from
code presented in https://www.pyimagesearch.com/2019/08/05/keras-learningrate-finder/. These minimum and maximum learning rates were used in a Cosine
annealing learning rate scheduler,
https://github.com/brianmanderson/Cyclical_Learning_Rate. The step-size was
varied to be 2000, 5000, or 10,000, with a reduction factor of 0.5.
Evaluating Training
Quantitative
Training was monitored using the TensorBoard module109 . The area under
the curve (AUC) was the metric of choice for overall model performance, but the
sensitivity and specificity at a 50% prediction cutoff were considered, as well. The
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top performing models, as identified by the highest AUCs, were selected for
prediction visualization.
Qualitative
To provide human interpretable explanations of the model predictions, we
use the integrated gradient (IG) method of identifying which aspect of the image
led to a model’s prediction. IGs were originally proposed by Sundarajaran et al.199
to identify which aspects of the image were most important in the decision
process. TensorFlow offers a tutorial on implementation of the IG method
(https://www.tensorflow.org/tutorials/interpretability/integrated_gradients)
which we adapted from 2D images to 3D images as seen in our data. Each top
performing model from among the eight possible input data presentations that are
given in Table 19 was investigated qualitatively.

6.3 Results
Quantitative
We present the results between the categories of ‘pre-treatment and
deformable post-treatment’ and ‘pre-treatment and rigidly registered posttreatment’. The accuracy, sensitivity, specificity, and AUC of for each data
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presentation method are presented in Table 20. Note that the sensitivity and
specificity are based upon a 50% prediction cutoff.
Table 20: Accuracy, percentage of progression sites accurately predicted, percentage
of non-progression sites accurately predicted, and the area under the curve (AUC)
values for the eight presentation methods of data. Note that accuracy and percentage
correct assume a prediction cut-off of 50%.
Description

Accuracy

Sensitivity

Specificity

AUC

Primary + Secondary Deform

67

18

95

0.66

Primary + Secondary Deform + Liver

70

23

97

0.68

Primary + Secondary Deform + GTV

77

55

89

0.81

70

36

89

0.78

Primary + Secondary Rigid

63

0

100

0.66

Primary + Secondary Rigid + Liver

67

32

87

0.66

Primary + Secondary Rigid + GTV

72

32

95

0.72

Primary + Secondary Rigid + GTV + Liver

67

23

92

0.75

Primary + Secondary Deform + GTV +
Liver

With the deformable registered images, increasing the information
presented to the model raised the overall performance from that of just the pretreatment and post-treatment images (AUC=0.66) to that of both the images and
the disease segmentation (AUC 0.81). Adding the liver to the deformed images and
disease segmentation produced a small decrease in the AUC. The received
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operating characteristic (ROC) curves for the individual data presentation methods
of pre-treatment and deformed post-treatment images are shown in Figure 72.

Figure 72: Receiver operating characteristic curves for each presentation of pretreatment and deformable registered post-treatment data to the model. The values of
the area under the curve (AUC) given in legend.
With the rigidly registered images, increasing the information presented to
the model raised the overall performance from that of just the pre-treatment and
post-treatment images (AUC=0.66) to that of both images, disease and liver
segmentation (AUC 0.75). Adding the liver to the images led to no increase in AUC,
while adding the disease increased AUC to 0.72, and adding the liver plus disease
further increased it to 0.75 while adding the disease segmentation led to a small
decrease in the AUC. The received operating characteristic (ROC) curves for the
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individual data presentation methods of pre-treatment and rigidly registered posttreatment images are shown in Figure 73.

Figure 73: Receiver operating characteristic lines for each presentation of pretreatment and rigidly registered post-treatment data to the model. The values of the
area under the curve (AUC) given in legend.
Qualitative
Qualitative visualization of the integrated gradients (IG) varied across the
models and sites. We used visualizations of the IG to qualitatively determine if a
model was focusing on aspects of the image that are relevant to the PTA procedure.
For example, in Figure 74, the model was presented with the pre-treatment image,
the rigidly registered post-treatment image, and the contours of the liver and
disease. Visualizing the IG, the model appears to be focusing mainly on regions of
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overlap between the ribs and lung, which is an artifact of the rigid registration,
rather than concentrating its attention near the disease site. This would lead us to
believe that the model’s prediction was based on aspects that we would consider
to be irrelevant to the decision process for this case.

Figure 74: Overlapping heat map from Integrated Gradients on a disease progression
case. Images (from left to right) are Pre-treatment CT, rigidly registered posttreatment CT, pre-treatment liver, disease, and post-treatment liver. Note that
disease is blank, as the disease is not present in these slices. However, the IG show
importance was heavily weighted on an area that is far from the disease.

Discussion
Among all eight models there appears to be a similar behavior of the AUC as
different data is presented. The presentations of the images alone for both rigid
and deformable perform equally poorly, with an AUC of 0.66. We believe this is due
to the model’s being presented with a relatively large search space without
guidance on the important aspects of the image, and that the limited overall
training data does not provide sufficient examples before overfitting occurs.
Adding the information of the liver segmentation provides a minimum
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improvement to the deformable registration model and none to the rigid
registration model, which is likely due to the fact that the data is centered on the
disease within the liver already. Thus, simply providing the liver contour doesn’t
inform the model much on important aspects. In addition, it may distract the
model since the entire liver boundary is not consistently presented in all of the
cases, causing additional random variability within the training set.
Both models show a marked improvement when adding the segmentation
of the disease information, rising from 0.66 to 0.81 with the deformable
registration model, and from 0.66 to 0.72 with rigid registration. We believe that
this information helps the model to focus more closely on what is important, that
being the disease and the corresponding ablation zone between the two images.
With the deformable registration model, adding the liver and disease
segmentations caused a slight decrease in performance. We believe that this is due
to the fact that the liver contour is not providing substantial new information in
the deformed model, as the two livers are already well registered to each other.
Visualization of the IG shows that the model sometimes focuses on the boundary
edge of the liver contour rather than the disease segmentation, shown in Figure 75.
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Figure 75: Overlay of the integrated gradients onto images presented to the
deformable model. From the left, the pre-treatment CT, post-treatment CT, liver
contour, and disease. Note that the IGs are focusing on the boundary of the liver
contour in the top right corner and not the disease.
In the rigid model, adding the liver with the disease contour provided a
slight increase in the AUC. We speculate that this is because the registration is not
perfect in the presence of deformation, and the liver contours help to orient the
model slightly. Despite this increase in the AUC, the rigid model’s best AUC is still
only 0.75, compared to 0.81 with the deformable registration model. We believe
that this is due to the rigid model’s inability to model the deformation of the
treated volume that occurs during the interval of time between the pre-treatment
and the post-treatment images.
It is important to note that the IG method does not tell the user exactly why
a decision was made. The confidence of a prediction by the model is not directly
tied to which aspects of the image would cause a certain output. For example, if the
model predicted that the treated site was likely to progress, the output
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visualizations are a representation of the question ‘which aspects of the image
would cause the model to predict progression with the highest confidence’. This
question can be asked of the model even if the model predicts that no progression
is likely to occur. For this reason, it is very important to look not only at the IG heat
map, but also at the model’s prediction confidence. Furthermore, if the model
predicts progression, but the IGs are not anywhere near the disease and ablation
volume, the user should be skeptical as to the benefit of the model’s prediction.
The IG can be useful not only for identifying regions of potentially
insufficient ablation, but also for assurances of sufficient ablation. In Figure 76, in a
case with no local progression, which the model accurately predicted as no
progression, we can see that the gradients are focused on the exact center of the
disease site and are fully encapsulated by the ablation cavity. We speculate that
this is the model’s identifying that sufficient ablation was delivered around each
aspect of the site.
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Figure 76: Overlapping heat map from the integrated gradients on a non-progression
case. Images (from left to right) are pre-treatment CT, deformable registered posttreatment CT, and disease segmentation. The model’s prediction of ‘non-progression’
appears to have focused entirely on the disease site encapsulated within the ablation
volume.
Exact metrics of what corresponds to a useful AUC can vary based on the
application. A score of 0.5 suggests the model has no ability to discriminate
between two outcomes, which is equivalent to the flip of a fair coin. Values from
0.7 to 0.8 are generally acceptable, 0.8-0.9 are excellent, and 0.9-1.0 are
outstanding200 .
Depending on the risk aversion of the user, he or she might prefer a higher
ratio of specificity to sensitivity, or vice-versa. For this work, we believe that a
higher sensitivity to local progression is more important, as it would hopefully lead
to identifying regions of insufficient ablation with the combination of prediction
and the IG map. The desire to be more conservative means that the user should
lean towards a potential addition ablation if the prediction of local progression is
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slightly less than 50%. This would lead to an increased sensitivity in identifying
patients with potentially insufficient ablation, but would also lead to an increase in
the number of patients receiving potentially unnecessary additional ablation. The
desired balance between these two potential outcomes will be determined by the
individual user, and his or her knowledge of the particular case that is being
treated.

Conclusion
We have created an outcome prediction model which assesses the
likelihood of outcome based on pre-treatment contrast-enhanced CT, a deformed
post-treatment contrast enhanced CT, and segmentations of the disease site with
an AUC of 0.81. Visualization of the integrated gradients for a given prediction
should be used to assess the efficacy of the model, and can help to identify
potential regions of interest in the treatment images. We believe that the
prediction output of the model along with the integrated gradients can help
provide meaningful information to the interventional radiologist.
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Chapter 7: Discussion and Future Work
Discussion
The main purpose of this work was to determine if we could distinguish the
patients who would develop local progression post-ablation therapy from those
who would not. We first performed a retrospective comparison of the measured
minimum distance to agreement in patients who were treated with PTA between
those with local progression and those without local progression, as outlined in
Chapter 4: The evaluation of local progression using biomechanical deformation to
reduce spatial uncertainties. The work presented justified using advanced imaging
guidance to measure minimum delivered ablation margin by finding that the 5 mm
minimum margin accurately differentiated progression from non-progression
patients (p<0.01). Furthermore, 93% (13/14) of the patients had spatial overlap
between progression and the 5 mm margin, showing that an inadequate minimum
margin was spatially indicative of future progression.
Following this preliminary work, we had two temporal impediments that
needed to be resolved before clinical implementation would be practical. Both
were segmentation related, being the segmentation of the whole liver, to run the
biomechanical modeling, and the segmentation of the disease and ablation zone,
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for minimum margin assessment. This necessity led us to create the DICOM RTStructure tool197 as discussed in Chapter 3: Technology created to facilitate work.
This tool facilitated not only the creation of image and mask arrays for training, but
also the conversion of deep learning prediction arrays back into DICOM-RT
Structure files to be imported in our treatment planning systems.
The autosegmentation of the whole liver, which is needed for the definition
of the boundary conditions in the creation of the biomechanical modeling, is
addressed in Chapter 5.0 Segmentation of the liver. We began by manually
acquiring and segmenting the liver on variable contrast and non-contrast
enhanced images at our institution. We found that without including non-contrast
images, our models increasingly over-segmented the normal tissue of the heart.
Between the 2D and the 3D architectures, we found that the 2D architecture built
on the DeepLab v3+ performed better in our quantitative comparison in the
segmentation task than did a 3D architecture. We believe that this is caused by two
main factors. First, the 2D segmentation model was built on a pre-trained Xception
backbone and therefore should require less data in the overall training process.
Second, 2D architectures inherently have fewer parameters for the same number
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of layers and kernel size. For example, a 3x3 convolution has 10 trainable
parameters, while a 3x3x3 convolution has 28. The reduced number of overall
parameters should lead to a smaller overall data requirement for training. While
2D architectures have limited field to a slice-by-slice basis, and therefore become
less confident in the inferior aspect of the liver, a simple seed-growing from the
prediction alleviated a large part of this issue. The final 2D model was preferred to
a manually drawn contour in 60% (30/50) of cases in a blinded comparison by
three physicians between previously defined manual contours and our model
contours. These results are consistent with work presented by other groups for
liver segmentation89,90,165,201 , and provided liver contours in a clinically actionable
(faster than 30 seconds) timeframe. It was in this work that we also showed the
importance of a qualitative assessment of segmentation models. One of the cases,
which was scored as requiring major editing, was a patient with a biliary stent,
which the model under-segmented, but it returned a Dice similarity coefficient of
0.94. Quantitatively this case was a success, but qualitatively it was deemed
clinically unacceptable.
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The autosegmentation of the disease and the ablation zone, which are
needed for the assessment of the minimum ablation margin delivery is addressed
in Chapter 5.1 Segmentation of the liver disease and ablation volume. We began this
task by retrieving publicly available data from the Liver Tumor Segmentation
(LiTS) challenge170 for training. We wanted to build the model using publicly
available data in order to facilitate other researchers’ leveraging our work. We
curated the data for the images that had hypo-enhancing regions, which are similar
in appearance to the ablation zone and colorectal liver metastases that are seen
during percutaneous ablation therapy. We investigated several architectures,
leveraging both pre-trained 2D fully convolutional networks with the DenseNet121 architecture, and 3D fully convolutional networks.
We first converted the DenseNet-121 2D classification network into a fully
convolutional network for segmentation. While this allowed us to reuse the pretrained features of the initial model, the final model struggled to identify the most
inferior and superior aspects of disease and a simple seed-growing was insufficient
to overcome this problem. In the training of the purely 3D architecture, we came to
the realization that we lacked sufficient data to create a robust model. Our final
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model, the ‘hybrid-WNet’, worked to leverage the pre-trained aspect of the 2D
architecture and then the 3D architecture for improved segmentation in the
inferior and superior aspect of the disease and ablation zone.
We quantitatively assessed the accuracy of our model with the publicly
available 3DIRCADb dataset171 and via submission to the LiTS challenge. Our
model had a similar performance to that seen in other segmentation models98,169 .
We further qualitatively evaluated the model based on a Likert-Score of 1-5, where
5 requires no editing and 4 requires editing taking less than 10 seconds by an
interventional radiologist, diagnostic radiologist, and radiology trained physician
fellow. The majority vote found 100% (24/24) of the disease contours and 84%
(16/19) of the ablation zones had a score of 4 or 5. We believe that the model
performed poorly on the ablation zones compared to disease sites due to having
few examples of ablation zones in the data. Moreover, the inter-observer Dice
similarity coefficient variability in the segmentation of colorectal liver metastasis is
relatively low, with a mean of 0.76, a minimum of 0.14, a maximum 0.92177 , and the
difficulty in identifying the exact boundary of the ablation zone led to difficulties in
defining the ground truth for evaluation.

201

We investigated a progression prediction model based on intra-procedural
imaging that was acquired during the PTA procedure in Chapter 6: Deep learning
outcome predictions model. We presented the model with a variety of inputs, from
rigidly registered, to deformable registered pre-treatment and post-ablation
images, as well as segmentation of the liver and disease. Our hopes were to provide
the interventional radiologists with both the likelihood of progression and human
interpretable images that would explain why the model was making its
predictions. We focused specifically on 3D implementations of the DenseNet 71 , and
evaluated the models based on the area under the curve (AUC). Overfitting was a
major challenge in this work, and we believe that the inclusion of more data would
be beneficial. To help mitigate the overfitting process, we investigated a the cosine
loss. While our final model selection reported an AUC of 0.81, visual evaluation of
the integrated gradients that led to the predictions shows that the model is capable
of making its decision based on information that appears extraneous to the
ablation procedure. We aim to provide the model prediction to the interventional
radiologist, as well as a mapping of the integrated gradients to help guide decision
making in ablation efficacy.
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Future Work
The liver segmentation model, because it is built on a 2D network, still has
cases of failure in the inferior aspect of the liver. In particular, when the prediction
goes near bowel structures in contrast-enhanced images it is known to oversegment. Furthermore, in the case of liver lobectomy and segmentectomy, the 2D
model can fail in what is an abnormal liver in appearance. We believe that this
failing is due to the 2D nature of the architecture. While 2D was able to perform
significantly better than our 3D architecture in our initial work, we believe that
this was due to the limited training dataset. This dataset can be dramatically
increased by leveraging the 2D model and making manual edits as needed.
Likewise, perhaps a 3D post-processing step would suffice to remove these oversegmentations.
The liver disease and ablation segmentation model appeared to work quite
well in disease segmentation, 100% (24/24) of the disease segmentations at our
institution were given a score of 4 or 5, but only 84% (16/19) of the ablation zone
segmentations had a score of 4 or 5. We believe this is due to the lack of
representation of ablation zones in the training data, and the difficulty in
consensus definition of ablation zones. Since the model is being used specifically
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for ablation therapy at our institution, it would be useful to retrain the model with
the inclusion of post-ablation segmentations from our recent patients. Having
multiple observers segment ablation zones can lead to a STAPLE segmentation,
and distribution of ground truth, varying from 0 to 1. This smoothing of the ground
truth label can be applied universally, or implemented directly on the ground
truth.
In the segmentation of the segments of the liver, a challenge was the large
inter-observer variability that was observed, and the naturally large variation in
the volumes of the different segments. Unfortunately, it also appears that the
segmentation ‘ground truth’ differs between surgeons and interventional
radiologists.
We tried to account for the variation in the volumes of the different
segments with a class weighting of each segment that is based on its fraction of the
overall volume. This means that the smallest segment, segment 1, would have an
overall higher weight than segments the combined 5-8, which occupy a much
larger volume. To try to mitigate the inter-observer segmentation variability, we
identified the standard deviation in the x, y, and z directions for the segmentation
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of each segment between multiple observers on a single patient. With label
smoothing, we scaled the ground truth confidence in the intersection between each
segment based on the identified standard deviation, varying the ‘ground truth’
from 0 to 1 between segments. The final model has not been qualitatively
evaluated, but the results were within the inter-observer variability that was
identified during training.
An interesting topic of research would be to investigate further the outcome
prediction model. This might include the incorporation of clinical factors into the
model and the visualization of the weights from the added clinical factors to
identify meaningful information outside of the ablation procedure. The human
interpretability aspect of the work, akin to what is seen in Figure 29, adds another
layer to ensure that the model is focused on regions of likely import. A spatial
correlation of the integrated gradients with the actual progression, similar to what
is shown in Chapter 4: The evaluation of local progression using biomechanical
deformation to reduce spatial uncertainties, could be a clinically useful
demonstration of identifying regions of insufficient ablation. While the final AUC
value of 0.81 is promising, the largest challenge of the training process has been
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dealing with overfitting on the limited dataset, and as more data becomes
available, we believe that the model could be significantly improved.

Conclusions
Our work led to the clinical implementation of a liver autocontouring
system that has provided over 1,800 segmentations on contrast, and non-contrast
enhanced CT scans as of 3/23/2021. The DICOM RT tools which we created to
facilitate this system are publicly available and have been downloaded 250 times
in the March 2021, https://pypistats.org/packages/dicomrttool. We have shown
that minimum ablation margins are a useful indicator of progression and that our
biomechanical modeling can reduce the spatial uncertainties in identifying these
minimum margins during percutaneous ablation therapy. The segmentations of
our liver, disease, and ablation volume have all enabled our Phase 2 Clinical Trial
(NCT04083378) by significantly reducing the segmentation impediments. Our
coding within the treatment planning system Raystation has created a useful
graphical user interface for the entire procedure, shown in Figure 77, and has tried
to ensure an easy transition of this work to the next users.

206

Figure 77: Graphical user interface created to run the mapping of disease from pretreatment to post-ablation contrast enhanced CT. User selects the primary and
secondary CT, as well as the boundary region of interest (ROI) and method. Selecting
GTV and Ablation ROI will map the disease and measure the minimum distance to
agreement.
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General Advice: Tips and Tricks
Several years have passed since the beginning of the work presented here.
Over that time, my knowledge of Python and Deep Learning has grown
considerably, as well as my own disbelief in how poorly my early coding appeared.
There are innumerable times where I realized previous work was grossly
inefficient, and, given a month, I would love nothing more than to completely
rewrite everything I have done. To that end, I want to include this section: Tips and
Tricks, as a section which would have benefited myself as a budding researcher in
both Python and Deep Learning.

General Python Advice
Comment code and make it modular
When I first started writing code it was very task-specific. I never bothered
created a definition for each part or commenting code because ‘it all made sense at
the time’. One of the most aggravating time sinks that I have encountered is going
back through my own code and trying to figure out exactly why I wrote certain
things. It also is poor practice when trying to share code.
If you have ever wondered ‘what style should I write my code in?’ there is
already a guide for that. I would recommend looking up the PEP-8 style guide for
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Python coding; there is a great tutorial here (https://realpython.com/pythonpep8/).
The final goal of code should be that it is easily interpretable and
reusable if needed.
Get comfortable with virtual environments
When I first started coding, I shied away from virtual environments. It
seemed like a daunting task to try to remember virtual environment names and
install packages when I could just have one main repository with everything.
Unfortunately, this makes it difficult when working with code from older sources
(specifically the versions of TensorFlow as the program shifted from 1.x to 2x.).
Most importantly, if the user wants to work on servers that run on Docker
files, having a quick way of identifying only the necessary packages and versions
can make Docker creation much simpler.
I would recommend looking at either conda or virtualenv. Instructions for
creating a virtual environment with virtualenv are available here
https://github.com/brianmanderson/Virtual-Environment-Instructions.
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Make a GitHub/GitLab!
The single most useful thing to the productivity of my PhD has been the
adoption of GitHub (or GitLab) into my research. Throughout my Master’s research
I had multiple times when small changes in the code would result in files with
suffixes like ‘DicomCode_New.py’, or ‘DicomCode_New_3.15.2020.py’, etc.
Unfortunately, when problems are realized, it is nearly impossible to go back days
or weeks later and identify exactly which changes caused the new behavior. To
that end, I cannot recommend strongly enough that a person interested in coding
create a GitHub/GitLab account and create a new project whenever he or she is are
working on something new.

Deep Learning advice
The advice below is generally written based on work that I have performed
in TensorFlow. I do not believe it is applicable only in TensorFlow, but ask the
reader’s forgiveness if this is the case.
On Data Preparation
Hands down the largest time sink for my deep learning work falls within the
definitions of ‘data preparation’. As the adage goes ‘garbage in, garbage out’, so
ensuring that the data you are working with is curated is vital. Furthermore, while
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deep learning’s ability to express complex problems is well known, it is important
that the data that is used to train the model be from a similar distribution as what
it will be evaluated on. A case in point is the failure of the liver segmentation model
to properly segmente the patient with ascites. Since patients with ascites were not
present in the training, it was not likely that the model would predict well on these
patients.
Curating Data
One of the first steps I take when going into a new project is try to visualize
the data distribution. For the segmentation of normal liver, this meant plotting the
measured liver volumes for the dataset. Data points which appeared to be outside
of the normal distribution (and were later identified as not including the GTV, or
only the bottom aspect of the liver) immediately led to further investigation, and
are significantly easier to identify as anomalies in a distribution than by going
through each patient’s data individually in isolation.
When working with DICOM data, I would also recommend pulling a list of
all of the region-of-interest (ROI) names. Just the name of an ROI can often say
much about whether it should be included in the data or not.
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On hyper-parameters
For any deep learning project, you will need to decide on an optimizer.
While I have always enjoyed trying the latest things, it is usually a safe bet to start
with a simple Adam optimizer. There is nothing to prevent you from changing it
later on, but when first trying to ensure that the architecture and loss are working
properly, keep the experimental things to a minimum.

On Architecture
When creating new architectures, start small. Creating a 20 layer deep
residual network for classification with 10 dense layers at the end is not only
difficult to train due to the number of parameters, but it can be very slow. A
smaller architecture will require significantly fewer resources, and can still
demonstrate if there are potentially fundamental problems with the architecture
you have created.
Visualize the model. Models can be saved as image files with the plot_model
functionality
(https://www.tensorflow.org/api_docs/python/tf/keras/utils/plot_model). A plot
can quickly identify if an architecture appears as imagined. An example of a simple
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classification model to identify if a dog is present in an image (Figure 78) with a
concatenation layer can be seen in Figure 79.

Figure 78: Example image of a dog for a classification network.
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Figure 79: Example of model visualization of a classification neural network.
Visualization helps ensure that concatenation properly occurs.
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Keeping track of hyper-parameters
Keeping track of hyper-parameter variations across your models is
extremely important. There is nothing worse than having a great model and not
knowing entirely which parameters led to its creation. Furthermore, training a
large number of models across a variety of hyper-parameters and having difficulty
identifying trends in the model performance can be particularly frustrating.
My first attempt was to write iteratively nested folders. For example, a
model with two layers, three convolution blocks, and the Adam optimizer would be
saved in the following folders: Layers_2 -> Convolution_blocks_3 ->
Optimizer_Adam. Now, beyond the fact that this becomes increasingly difficult to
search through, certain machines (like Windows) have a maximum path limit that
can cause larger problems down the line.
The best method that I have come up with is to refer to everything in an
Excel sheet. The first column can be a ‘Model_Index’, this is something that iterates
upwards from 0 to infinity as you create models. The rest of the columns are
hyper-parameters, from the number of layers, to minimum and maximum learning
rate, shown in Figure 80. The models are then stored in a relatively flat file
directory structure that is accessed by the model index.
215

Figure 80: Example of excel sheet which maintains unique model_indexes for each
model as well as the hyper-parameters which define those models.
As you train your models, save them into folders that reflect the
Model_Index, this will keep your model folders clean and easy to find.
There are several benefits to this process, the first being that each model
you create will have a unique identifier in the Model_Index and will have every
parameter in the creation of that model recorded. Second, the model performance
can easily be added to the excel sheet by associating it with the Model_Index. Code
to read the TensorFlow event files can be found at
https://github.com/brianmanderson/Finding_Optimization_Parameters, in
History_Plotter_TF2.py. With the metrics added, trends can easily be visualized
using ggplot. You can easily identify trends as shown in Figure 81.
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Figure 81: Example of validation Dice Similarity Coefficient vs number of layers and
max_filters using ggplot.
On Training
When training a model, it is important to understand exactly what you are
optimizing the model to do. Understanding the right loss function is particularly
important for this. For segmentation tasks, the categorical cross entropy is a solid
choice, while for predicting deformation vector fields something like the mean
square error is a good choice. For whatever task you are attempting, do your best
to visualize the process as the model trains. There is no worse feeling than wasting
time on what you believe to be a good model, only to run a prediction and see
garbage on the output.
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Pipeline Visualization
When training a large number of models with various parameters, you want
your model training to be as efficient as possible. TensorBoard offers an
interesting functionality called ‘Profiler’, which will generate a report based on the
time spent performing certain tasks throughout training. The profiler can be a
quick way of identifying the rate-limiting steps in your current training process, as
shown in Figure 82.

Figure 82: Step-time graph from profiler in TensorBoard
A full explanation of the profiler is provided by TensorFlow,
https://www.tensorflow.org/tensorboard/tensorboard_profiling_keras. This also leads
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nicely into more efficient data generators for the training and data presentation process
https://www.tensorflow.org/guide/data_performance.
Visualization
TensorFlow offers increasingly intuitive tools for creating callbacks during
model training. For segmentation work, we have created a visualization callback that
creates images within TensorBoard, shown in Figure 83.

Figure 83: General appearance of TensorBoard with images generated during
training.
An example of some of the images that were generated during our work on
semantic segmentation of the liver segments can be seen in Figure 84.

Figure 84: Example of images produced from our imaging callback. Top: masked
images of the liver. Middle: Ground truth annotations. Bottom: Predictions.
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The code can be found on our Github page
https://github.com/brianmanderson/Callbacks/blob/master/TF2_Callbacks.py in the
function Add_Images_and_LR.

A final note
Coding can be confusing, frustrating, and make you feel like an absolute idiot.
Coding can also be incredibly rewarding and make your life a great deal easier. Rarely
do you always feel one way or the other, although more often than not you will
probably feel like an idiot. Do not get down on yourself; rarely does someone master a
skill without first failing many, many times. Remember that the coding community is
(in general) an open and sharing environment, and please always feel free to reach out
through the email listed on my GitHub https://github.com/brianmanderson.
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